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Francisella tularensis was a facultative intracellular pathogen and a gram-negative 
coccobacillus which has been categorized by the CDC as a potential class A select agent 
due to its highly infectious properties and high mortality rates.  Francisella tularensis 
was also responsible for the zoonotic disease tularemia, which was usually transmitted by 
arthropod vectors or via contact with infected animals.  Francisella tularensis subspecies 
novicida has been used by many researchers in genetic pathogenesis experiments to try to 
elucidate genes responsible for virulence factors.  One of these virulence factors was a 
capsular material which has been thought to be involved in either increasing 
pathogenicity or infectivity of this organism upon engulfment by its principal host cell, 
the macrophage.  There were many potential genetic loci which may be involved in this 
 xv 
biosynthetic process of encapsulation.  One such locus has excellent homology to the 
capsule biosynthesis operon of Bacillus anthracis, which, under certain conditions, 
creates a polyglutamic acid capsule (PGA).  A transposon mutation in the amide ligase 
(capB) in LVS has a reduced virulence in murine infection models.  I wished to 
investigate whether Francisella novicida was capable of producing such a capsule and 
under which environmental conditions this capsule was made.  I have created a site-
directed mutant of the capB gene in Francisella novicida U112 using targeted 
mutagenesis via PCR SOEing and have introduced this mutation via electroporation of a 
suicide vector.  I have tested our mutant against preimmune serum treatments and have 
shown reduced viability as well as a reduced capacity for replication inside RAW 264.7 
murine macrophages.  I assayed for production of a PGA capsule via immunodot blot and 
electron microscopy as well as analysis by mass spectrophotometry of capsular extracts.  
I also tested various media constituents and different environmental conditions to 
determine which external stimuli may contribute to PGA capsule biosynthesis as well as 
regulatory changes in transcript levels of this operon. 
 
CHAPTER ONE:  INTRODUCTION 
 
Background 
 Francisella tularensis was a gram negative coccobacillus bacteria and was 
classified as a facultative intracellular pathogen, in which it can survive outside a host in 
the environment.  It was highly infectious, with as few as ten organisms causing disease 
in compromised individuals, and can be easily disseminated.  It was classified by the 
Center of Disease Control and Prevention as a category A select agent.  The organisms, 
viruses, and toxins which comprise this list were known to have the potential to cause 
widespread disease, produce high levels of morbidity and mortality if not treated, and 
usually require specialized care and therapy for resolution.  Francisella tularensis causes 
the zoonotic disease tularemia, which originally was discovered in Tulare County, 
California causing a plaque-like illness in local ground squirrels in 1911.  The organism 
isolated from these animals was originally called Bacterium tularense, after the site of 
disease origin.  In 1947, it was later renamed after the famous public health surgeon, Dr. 
Edward Francis, who dedicated his life to the study of this organism and the disease it 
causes.  Tularemia was usually associated with rodents, rabbits, muskrats, and voles and 
has been nicknamed rabbit fever.  In the 1930s and 40s, large waterborne outbreaks of 
tularemia occurred in regions of the Soviet Union and Europe.  The largest outbreak on 
record occurred in Sweden in 1966 through 1967, in which over 600 farmers became 
infected due to the aerosolization of bacteria in rodent-infested hay (47, 111). 
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Transmission 
 Tularemia was usually transmitted in one of four ways: direct contact with 
infected animals, arthropod-borne, ingestion, or aerosolization.  The severity of disease 
can be associated with the route of infection.  There were many known reservoirs of 
Francisella, including 14 species of ticks, 6 species of flies, many known mosquito 
species, several hundred species of mammals, and several bird species.  While most cases 
in the United States involve ticks or mammal exposure, there was a known rodent-
mosquito cycle which takes place in the northern climes of Russia and Sweden.  Direct 
contamination was usually due to the handling of skins or tissue of infected animals, and 
was mostly associated with the occupational hazards of animal handlers or farmers.  Bites 
from infected animals have resulted in transmission, however this occurs rather 
infrequently.  Ticks infected with Francisella were usually infective for life and there 
was evidence of transovarial transmission, in which female ticks pass the bacteria on to 
their offspring.  Tick species known to transmit tularemia include Dermacentor 
andersonii, Dermacentor variabilis, and Amblyomma americanum.  The mosquito 
species of Aedes, Anopheles, and Culex have been known to transmit tularemia as well.  
The deerfly Chrysops discalis was also known to transmit this disease, although 
infrequently.  Humans were usually accidental hosts in this life cycle.  Ingestion of 
relatively larger amounts of bacteria has been the source of waterborne outbreaks, and 
disease has resulted from the ingestion of contaminated meat.  Some water borne cases 
have been affiliated with amoebae, such as Acanthamoeba, and it was known that these 
bacteria can persist in these single-celled organisms for some time.  Aerosolization of 
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bacteria due to contaminated hay and soil as well as laboratory accidents have produced 
many instances of pneumonic tularemia.  The fairly recent occurrence of exposure to 
laboratory workers at the clinical microbiology lab at Boston Medical Center clarifies the 
importance of established select agent protocols and laboratory notification of potentially 
dangerous organisms (152, 156).  There have been no reported incidences of person to 
person transmission. 
 
Utilization as bioweapon 
 Due to its infectivity and its ease of dissemination, Francisella tularensis has 
been an agent of interest to the military as a biological weapon and was developed and 
mass produced in both the United States and the Soviet Union in the early 1950s.  One of 
the most virulent strains of Francisella was weaponized for use in the M143 bursting 
spherical bomblet.  It was believed that in the Soviet Union, strains of Francisella were 
engineered to withstand various antibiotics and vaccine therapies as late as 1990.  In 
1972, the Biological and Toxic Weapons Convention was signed by the United States 
prohibiting the development, production and stockpiling of microbes or their poisonous 
products except in amounts necessary for protective and peaceful research.  As of 1996, 
137 different countries had ratified this treaty, however it was believed that several 
countries have ignored the specifics of this treaty and have continued production of 
biological weapons (111). 
 It has been suggested by Dr. Ken Alibek and a former Russian LTC that Russia 
used tularemia as a bioweapon at the onset of the Battle of Stalingrad in the fall of 1942.  
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It was recorded that Russia had already lost a least a million soldiers that preceding year, 
and when it become clear that the German forces (6th and 17th Armies) were pushing 
toward Stalingrad, Stalin ordered Order 227, in which “every granule of Soviet soil must 
be defended to the last drop of blood.”  That fall over one hundred thousand cases of 
tularemia (the majority of these were pulmonary infections) befell the soldiers, first the 
Germans, but then the Russians too were affected.  Subsequent reports, however, have 
cast doubt on these suggestions, as tularemia was endemic to these regions of Russia, and 
that the severe conditions of the front promoted these infections.  It has been reported that 
the regional crops had not been harvested and that by winter, the number of rodents 
cohabiting with soldiers was extreme.  Soldiers from both sides were bedding in straw as 
well as eating rations frequently tainted with dead rodents (1). 
 In 1969, the World Health Organization (WHO) estimated that if 50 kg of virulent 
F. tularensis particles were aerosolized over a city with 5 million people, the result would 
be 250,000 illnesses and 19,000 deaths. Illness would be expected to persist for several 
weeks and disease relapses would occur during the following weeks or months. Recently, 
the Centers for Disease Control and Prevention (CDC) estimated the economic impact 
associated with an outbreak of tularemia to be $5.4 billion for every 100,000 people 
exposed (total base cost to society) (75, 187). 
 
Epidemiology, disease, and treatment 
 Tularemia was usually found in the northern hemisphere in countries such as the 
United States, Russia, Europe, Japan, and Scandinavia.  Cases have been reported as far 
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as south as Australia.  In the U.S., about 200 cases were reported each year and were 
usually located in Midwestern states, such as Oklahoma, Missouri, and Arkansas.  
Human disease can usually be linked to increased prevalence of tularemia in local 
wildlife. 
 Tularemia as a disease usually manifests itself in one of six clinical syndromes: 
ulceroglandular (the most prevalent form), glandular, oropharyngeal, oculoglandular, 
typhoidal, and pulmonary (usually the most lethal).  These manifestations depend on the 
route of infection, the particular strain, and the inoculum size.  All of these forms, 
however, usually start with headache, sudden fever, myalgia, and chills after three to ten 
days of incubation.  Bacteria were usually be found disseminated to the spleen, liver, 
lungs, kidneys, and other sites which harbor cells of the reticuloendothelial system.  The 
glandular symptoms were the result of infected lymphatics and present as the classic 
enlarged buboes and lymphadenopathy similar to bubonic plaque.  The most mortality 
(30 to 60%) was seen with typhoidal and pulmonary tularemia, which, if left untreated, 
may result in shock and pneumonia, respectively.  Pulmonary tularemia was usually due 
to the inhalation of infectious organisms via aerosolization (47). 
 Treatment of this disease can be successful, however, history has shown that early 
and the correct antibiotic regimen against tularemia was paramount.  Streptomycin and 
gentamicin were effective against Francisella and were bactericidal antibiotics.  
Ciprofloxacin has been a favorite choice of treatment due to its efficacy in pediatric cases 
as well as against relapses of diseases when initial therapy was not successful.  
Doxycycline was another favorite due to its low cost.  Bacteriostatic drugs against 
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Francisella include tetracycline and chloramphenicol, which require longer treatment 
regimens.  It has been shown that Francisella was resistant to most beta-lactams and 
azithromycin via in vitro suspectibility tests (43). 
 
Description of Francisella subspecies 
 There were five main subspecies of Francisella tularensis:  tularensis, 
mediasiatica, holarctica, novicida, and japonica.  Francisella tularensis tularensis has 
been classified as type A, has the highest virulence of the subspecies, and requires 
manipulation in a BSL-3 laboratory.  Francisella tularensis holarctica has less virulence 
and was classified as a type B organism.  One strain of holarctica, LVS (live vaccine 
strain), has been used as a vaccine in the past against tularemic infections, however, the 
identification of the attenuation of this strain has never been uncovered which prevents its 
licensure with the FDA.  Francisella tularensis novicida has been shown to be less 
virulent to humans and presents a tularemia like illness in animal models.  Francisella 
novicida has nearly identical 16S ribosomal DNA to Francisella tularensis, but lacks a 
second copy of the Francisella pathogenicity island (FPI) which was essential to 
intracellular growth in macrophages (33, 115).  It has also been established that novicida 
has a functioning restriction system, making transformation experiments more difficult.  
These characteristics have made this strain a choice of many researchers hoping to 
uncover the many various virulence factors responsible for its pathogenesis.  This 
organism has many ORFs that do not match with known proteins of other bacteria, and 
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were deemed unique.  In general, the Francisella genome has a relatively low G+C 
content (34%) and a small length of ~ 1.8Mbp (16). 
 
Bacterial capsule as a virulence factor 
 Little was known regarding the virulence factors responsible for Francisella’s 
pathogenesis.  No information has been found regarding the presence of secreted toxins, 
although evidence of genes for pili formation and type I (ATP-binding cassette proteins) 
secretion exist (192).  It was also known that the lipopolysaccharide (LPS) for 
Francisella does not elicit the same type of immune response characteristic of gram-
negative bacteria.  It does not cause the induction of IL-1 nor the strong induction of 
TNFα from macrophages. 
 Many bacteria produce a protective barrier around themselves traditionally 
comprised of polysaccharides and attached to either the outer membrane or the 
peptidoglycan layer called a capsule.  This protective barrier can have many different 
properties depending on the bacteria and the nature of the capsule.  Usually the capsule 
was made of a polymer of a weakly immunogenic material which can be used to aid the 
bacteria in avoiding aspects of both the innate and adaptive immune responses.  Some 
capsules were able to inactivate complement by disrupting the formation of the MAC 
complex on the bacterial surface.  Others mask pathogen-associated molecular patterns 
that may be recognized by instruments of the adaptive immune response.  Some capsules 
give their bacteria adhesive properties so that may cluster and inhibit antibiotics or other 
bactericidal materials.  Still others provide an ionic shell which aid certain bacteria from 
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desiccation as well as act as a hydrophilic barrier which can also protect the bacteria 
during stringent conditions.  It can also act as an ionphilic barrier for important cations 
needed by the bacteria cell for metabolism.  Historically, it has been shown that with 
many bacteria, if they were stripped of their capsular material, that the virulence potential 
for that organism in in vitro infection experiments or animal models was greatly reduced.  
A classic example of this would be the smooth:rough Streptococcus experiments 
performed by Avery.  The bacterial capsule of Francisella has been an object of 
contention amongst many researchers, many of which, in years past, questioned its 
existence.  However, Dr. Hood’s analysis of the capsular material recovered from the 
virulent F. tularensis Schu S4 strain showed evidence of mannose, rhamnose, galactose, 
and two forms of fatty acid (68).  It has been said however, that these samples may have 
been contaminated with LPS, and that additional analysis was necessary.  Dr. 
Cherwonogrodsky published a seminal paper in 1994 in which he demonstrated an 
increase in both encapsulation and virulence with repeated growth of Francisella in the 
synthetic Chamberlain’s media (32).  Although there was no isolation or analysis of 
capsular material, the capsule was visualized by transmission electron microscopy and 
the reduction in viability of test animals was demonstrated in infection models.  In recent 
years, Drs. Apicella and Inzana have elucidated the capsule of Francisella using 
immunoelectron microscopy with antibodies specific for individual sugars which 
comprise the capsule.  Its relevance and role in pathogeneticity was still questioned, 
however, as Dr. Golovliov has presented data showing the loss of capsular material upon 
 9 
phagolysosome entry by the bacteria in macrophage infection and that the capsular 
material may be involved in the actual escape of bacteria from the phagolysosome (57). 
 Genetically, the genes responsible for biosynthesis of this polysaccharide capsule 
have been elucidated and were in proximity with the genes responsible for O-antigen 
synthesis.  Mutants have been made of several of these genes (manC, manB, and GGT) 
and the loss of capsular material has been observed (unpublished material).  There were, 
however, other genes present in Francisella which could potentially encode for a protein 
capsule. 
 
Characteristics of polyglutamic acid 
 Many of the Bacillus species encode for a capsule which consists of poly-γ-
glutamic acid (PGA), a nonribosomal polyamino polymer that can be covalently attached 
or secreted from the bacteria.  PGA was found usually in gram positive bacteria and when 
attached, was anchored to the peptidoglycan layer.  Attachment of PGA to this layer was 
dependent on the expression of capD, which encodes a γ-glutamyltranspeptidase, which 
was also thought to be integral in PGA degradation.  A recent capD mutation in 
Francisella (referred to as GGT) was found to have low intracellular viability not due to 
effects on polymerization of PGA, but due to its importance in the breakdown of 
glutathione for cysteine acquistion (2).  PGA can be formed entirely of D-glutamate, as 
was the case in Bacillus anthracis, or consist of both isomer forms, D+L.  Polymers 
consisting solely of L-glutamate were the rarest form of PGA.  Isomers of glutamate were 
possible via glutamate racemase, which exists in Francisella.  The potential for 
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isomerization was important as polymers consisting of a singular form of glutamate will 
act as a thymus-independent type 2 antigen and will be incapable of inducing 
immunoglobulin class switching (183).  It has been shown that PGA provides certain 
bacteria (ie. Staphylococcus epidermidis) salt tolerance and also gives B. anthracis 
antiphagocytic properties.  PGA may also be a storage of both nitrogen and carbon in 
periods of starvation.  PGA was polyanionic in nature and was highly water soluble, 
which aids in its hydrophilic properties (25, 63).  Measurement of PGA from bacteria can 
be difficult as traditional protein assays such as Bradford and Lowery were not effective 
(1.25 mg/ml of L-glutamic acid solution measures as 0.42 µg/ml in the Bradford assay).  
PGA also does not stain with Coomassie blue in SDS-PAGE experiments (188).  Polymer 
size usually varies due to the organism, but can measure from 160 kDa to 1500 kDa (> 
1000 residues). 
 
Gene operon of polyglutamic acid 
In B. anthracis, this protein capsule operon was encoded by the plasmid OX2, 
which may have the propensity to transpose to other bacteria (12, 60).  This operon 
consists of capA, capB, capC, capD, and capE genes (6).  Some ambiguity still exists 
regarding whether capE was essential for polymerization to occur, as PGA has been 
created in reengineered tobacco plants with only the A, B, and C orthologs (169).  The 
genes for capA, capB, and capC were located together in the Francisella novicida U112 
genome at position 1272800, while it was believed that the analog for capD was located 
upstream at position 1229837.  There were many lines of evidence that point to the  
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Figure 1 A and B.  The structure of polyglutamic acid, the organisms which produce 
PGA, and confirmation of known polymers.  A)  PGA was made up as an anionic 
polymer of glutamic acid residues connected by gamma linkages, which were resistant to 
protease activity.  These linkages provide PGA with specific properties.  B)  Many 
organisms were known to produce PGA and were capable of several different 
configurations of polymer, depending on the enantiomers of glutamate available. 
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adapted from Candela T. and Fouet A. Molecular Microbiology 60: 1091-98 
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production of a PGA capsule by Francisella.  First, several bacteria have been identified 
to contain the cap operon within their genome, with a few of these not being traditional 
gram-positive bacteria, such as Leptospira interrogans and Fusobacterium nucleatum 
(79).  Second, Francisella has excellent homology (>50%) to most of these genes, and 
ablation of several of these genes has phenotypic effects (161).  Third, it has been shown 
that gram-negative bacteria were capable of producing PGA.  Dr. Ashiuchi reengineered 
E. coli bacteria with expression vectors to express the cap operon in an attempt to mass-
produce PGA for industrial purposes.  PGA has many uses such as a food preservative, a 
cryoprotectant, a cosmetic thickener, and as a biological adhesive.  Dr. Ashiuchi found 
that the reengineered E. coli could produce PGA, however, at a much lesser yield (9).  
And finally, Dr. Su, in his transposon mutagenesis experiments of LVS, demonstrated a 
substantial decrease in virulence of the capB mutant in murine animal co-infection 
models.  This data was supported by the generation of site-directed mutagenesis of this 
same gene to rule out the effects of potential transposon integration at other sites besides 
this gene of interest.  Similar attenuation of virulence was seen (161). 
The capB gene of this operon traditionally encodes an amide ligase, which was 
responsible for the gamma bond linkage between molecules of glutamic acid.  This was 
the bonding of the gamma carboxyl group of glutamate to the amine group of the next 
glutamate.  This linkage gives the polymer additional properties beyond the usual alpha 
peptide linkage.  The gamma linkage was resistant to proteases unlike the alpha linkage.  
The polymerization of PGA requires ATP and the genetic sequence of capB has a 
consensus ATPase motif early in its sequence (GIRGKS).  Unfortunately, the membrane 
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structure and organization of this enzyme and its protein-protein interactions have not 
been uncovered as isolation of this membrane protein complex was unstable.  It was 
believed that CapB and CapC form a complex together due to the increase in ATPase 
activity and that these proteins were mainly involved in polymerization (25, 107). 
 
Mutagenesis of Francisella 
Transposon mutagenesis of Francisella has been successful in elucidating many 
gene functions of unknown reading frames as well as genes required for intracellular 
growth, but for a long time, no confident allelic exchange system existed for site-directed 
mutagenesis of particular genes.  Initial vectors designed for allelic exchange in 
Francisella lacked species-specific promoters driving various antibiotic cassettes.  
Similar transposon elements without Francisella-specific promoters also failed to be 
successful instruments of mutagenesis (54).  The development of the pFNLTP series of 
plasmids by Dr. Tamara Maier opened the door for site-directed mutagenesis in 
Francisella (105).  These series of plasmids were the result of integrating pTOPO with 
pFNL10, a native plasmid from Francisella novicida F6168 (120).  This construct was 
electroporated in LVS and the resulting plasmids had deletions at the fusion point 
between these two original plasmids.  However, these plasmids were functional shuttle 
vectors between Francisella and E. coli species and were relatively stable with repeated 
passage in these organisms.  Dr. Karl Klose used these principles to design the pKEK887 
plasmid which has a Francisella novicida FTN1451 promoter driving the erythromycin 
resistance gene (94).  Unlike the pFNLTP series, however, this plasmid lacks the ability 
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to replicate in Francisella, making it an excellent candidate for use as a suicide vector in 
targeted insertion experiments for site-directed mutagenesis.  The Klose plasmid also 
creates nonpolar mutations, depending on the selection of the flanking DNA around the 
desired target.  Only certain antibiotic cassettes can be used in recombination 
experiments in Francisella due to the nature of this organism and as a member of the 
select agents of bioterrorism.  The pKEK887 was used here to create a targeted insertion 
of the erythromycin cassette into the capB gene of Francisella tularensis novicida U112. 
 
Environmental factors involving encapsulation 
Many different environmental factors were known to induce the biosynthesis of 
encapsulation of bacteria.  The PGA capsule of Staphylococcus epidermidis was induced 
by increases in NaCl concentration, and this capsule helps protect S. epidermidis from 
high salinity (79).  In Bacillus anthracis, PGA encapsulation was induced with incubation 
of the bacteria in 5 to 10% carbon dioxide.  The addition of sodium bicarbonate plus 
similar levels of carbon dioxide has been shown to increase PGA production in the 
reengineered E. coli (6, 9).  In other Bacillus species, the presence of Mg2+ or Mn2+ 
increases capsule production.  Various methods will be attempted to try to induce PGA 
capsule production in Francisella novicida. 
 
Research objectives 
The purpose of this dissertation project was to try to visualize the PGA capsule of 
Francisella novicida and to identify particular external stimuli that will facilitate its 
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biosynthesis.  Its role in pathogenesis will also be investigated.  My research has been 
separated into three specific aims: 
 
Isolate and characterize PGA mutants 
Site-directed mutagenesis of the capB gene in Francisella novicida was used to ablate the 
amide ligase activity of this gene’s product.  A suicide vector generated by PCR SOEing 
was introduced into Francisella novicida by electroporation.  Loss of the transcript of 
capB will be confirmed by RT-PCR and characterization assays for the loss of 
encapsulation were performed. 
 
Demonstrate potential PGA production 
Immunoelectron micrographs using transmission electron microscopy was used with 
antibodies specific for PGA to try to visualize the PGA capsule of Francisella novicida.  
Extractions from the outer membrane were also be analyzed by mass spectrophotometry 
and amino acid analysis for presence of PGA. 
 
Determine environmental factors which may influence PGA production 
Various growth conditions were examined in order to determine which may promote 
PGA encapsulation of Francisella novicida.  Outer membrane extractions from various 
growth conditions were blotted with the same antibodies used in the immunoelectron 
micrographs. 
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CHAPTER TWO:  MATERIALS AND METHODS 
 
Bacterial isolates, macrophage cell line, and cultivation conditions 
 Francisella novicida U112 was provided by Dr. Karl Klose from University of 
Texas, San Antonio.  U112 was grown principally in three types of media:  Trypticase 
Soy Broth with 1% cysteine hydrochloride (TSB-C), Chamberlain’s defined media 
(CDM), or M9 minimal media plus 1% cysteine hydrochloride, all at 37°C.  For 
molecular cloning, E. coli DH5α was used for all plasmid propagation and grown at 37°C 
in Luria Broth.  Klebsiella pneumoniae was also grown at 37°C in Luria Broth.  Bacillus 
licheniformis ATCC 9945 was provided by Dr. Thomas Kozel and was grown in PGA 
media at 30°C (177).  Spectrophotometric measurements were made on a Bio-Rad 
SmartSpec Plus.  RAW 264.7 murine macrophages were provided by Dr. Suzanne 
Barbour and were grown at 37°C with 5% CO2 in DMEM with 10% heat-inactivated 
fetal bovine serum and 1mM nonessential amino acids (all media components from 
Gibco-BRL). 
 
Construction of suicide vector, pEF25 
 In order to create Francisella homologous DNA fragments needed for proper 
recombination with the U112 genome, genomic DNA was extracted from inocula of 
Francisella novicida U112 grown overnight in Trypticase Soy Broth with 1% cysteine 
hydrochloride using the Epicentre DNA extraction kit.  Extracted genomic DNA (100 ng) 
was used as template in PCR reactions with primers listed in table 1.  PCR was 
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performed using a MJ Research PTC-200 Thermocycler and using the Pfu polymerase 
(Stratagene).  The erthyromycin cassette of pKEK887 was used as template for the 
antibiotic marker for this suicide vector.  This vector has a Francisella novicida promoter 
driving the erthyromycin cassette, which was essential for expression of the cassette (94).  
Once all three PCR fragments were created and isolated from 1% agarose electrophoresis 
by the QIAGEN gel extraction kit, these DNAs were combined together into a single 
PCR SOEing reaction.  The resulting fragment of ~3kb was subsequently restriction 
digested with SalI and ligated using NEB T4 ligase into pBlueScript SK+ plasmid using 
blue / white selection and selection for erthyromycin resistance at 100 µg/ml.  Resultant 
colonies were initially verified for accuracy by MW via 1% agarose electrophoresis and 
additionally verified by QIAGEN plasmid prep DNA restriction with Sal I, liberating the 
DNA insert from the plasmid.  One was designated pEF25. 
 
Electroporation of pEF25 into U112 
 1 µg of pEF25 DNA resuspended in milliQ water was mixed together with 100 µl 
of thawed competent U112 in a 0.2 cm electroporation cuvette.  These bacteria were 
made competent after overnight growth in TSB plus 1% cysteine to an OD600 of 1.5, 
washed twice in 0.5M sucrose, and frozen to –80°C.  The electroporation was performed 
as in Pavelka (97), at room temperature in a Bio-Rad Gene Pulser set at 2.5kV, 25 µF, 
and 600 ohms.  The inoculum was then placed into 1ml of TSB plus 1% cysteine for a 
two hour recovery period in a shaking incubator at 37°C.  The inoculum was then plated 
to TSB plates with 1% cysteine and 100 µg/ml erythromycin for two days at 37°C. 
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RT-PCR / PCR for capB knockout confirmation 
 RNA was isolated from wildtype and mutant bacteria using the RNAeasy 
QIAGEN extraction method and resuspended in DEPC-treated water.  RNA was checked 
for quality by spectrophotometry and 260 / 280 ratio.  2 µg of RNA was used in an 
Invitrogen Thermoscript RT-PCR system to convert RNA to cDNA, utilizing the random 
hexamer protocol.  Subsequent Taq PCR was performed using primers from table 1 under 
the following conditions: 1 cycle at 94°C for 2 min, followed by 30 cycles of 94°C for 30 
seconds; 56°C for 30 seconds; 72°C for 1 min, 30 seconds; and an extension period at 
72°C for 7 min.  Presence of cDNA products was confirmed via 1% agarose gel 
electrophoresis. 
 
Growth curves and growth conditions 
 Two hour timepoint measurements of OD600 were made for logarithmic growth 
curves of bacterial cultures inoculated by normalized amounts from overnight cultures in 
TSB plus 1% cysteine or Chamberlain’s defined medium (CDM).  Various media were 
used including supplemented 0.5M, 1M, 1.5M, and 2M NaCl; 10mM, 25mM, 50mM, 
100mM, 150mM, and 200mM MgSO4; 50mM L-glutamic acid; and 10% carbon dioxide 
plus 0.5 to 1% NaHCO3.  Subtractive media were used as well, such as CDM without 
ferrous chloride; spermidine; and M9 minimal media plus 1% cysteine and without 
carbon sources.  Congo Red was added to various agar media at a concentration of 100 
µg/ml. 
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    TABLE 1 
NAME RS PRIMER 
UniUP  TGCATTAGGAAGCAGCCCAGTAGT 
UniDN  TTCCTTTCGGGCTTTGTTAGCAGC 
CapCF1 Sal I GATGCTGTCGACCCCATTGTCTTACATAGATAGC 
U112CapR1 ACTACTGGGCTGCTTCCTAATGCAGGAGTTGGTA 
   ATATTAAAGATATTGG 
U112CapF2 GCTGCTAACAAAGCCCGAAAGGAACTACTGTTCT 
   ATATCCTCCAGC 
U112CapR2 Sal I GATGCTGTCGACCAATTGCTTTATCGGCTTATGC 
CapB2F  GCACAAAGCTTATCCCAAAGC 
CapB2R  GCAGCTACTGTCCCTGTTGGAG 
SpoT2F  TAACCATGCCGGATTAGGATCAGCA 
SpoT2R  CAGTTGGAAACTCTTGCGTTTGAG 
PolA2F  TGGAGGAAGTCCTAGCTTCTCGAA 
PolA2R  CAGCTTGATGATCTGATTGCGGA 
CapC1F  ATCCAGGTACAACCATACCAC 
CapC1R  TGGATCCGTTAACGCTCTCGA 
     
   PLASMIDS 
pFNL10  native plasmid from F. novicida F6168 
pFNLTP  F. tularensis / E. coli shuttle plasmids derived from  
   integration of pTOPO and pFNL10 
pFT7T  pFNLTP7 shuttle plasmid with oriT addition 
pKEK887  pET15b based plasmid with FTN_1451 promoter for  
   Erm cassette 
pEF25  pBluescript SK + plus flanking capB U112 genomic  
    sequences and Erm cassette 
RS = restriction sites 
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Immunoelectron microscopy 
 Immunoelectron micrographs were created similar to the Sebastian protocol 
(150).  200-mesh Formvar carbon-coated copper grids were dropped onto 8 µl drops of 
bacteria for 1 min.  The grids were then blocked in 0.5% fishskin gelatin in PBS with 
0.1% Tween 20 for 5 min.  Primary antibody diluted to 1:20 in PBS was placed onto 
these grids for a 20 min incubation, then washed for 1 min in 0.1 x PBS-Tween.  Gold 
colloidal beads bound to Protein A were used as a secondary antibody diluted to 1:10 for 
another 20 min incubation.  The grids were then washed in milliQ water twice for 1 min 
each.  Grids were then dried overnight and visualized by a JEOL JEM-1230 TEM (70).  
Primary antibodies included a F26G3 monoclonal from Dr. Thomas Kozel (80) and a 
polyclonal from Dr. Rachel Schneerson (148), both against polyglutamic acid.  
Preimmune sera were used as a control. 
 
Sodium deoxycholate and serum sensitivity assays 
 Both of these assays were modeled from assays performed by Cowley (39).  
Overnight cultures of bacteria were centrifuged down and washed twice in PBS.  These 
bacteria were then diluted to 105 CFU / ml and 100 µl were plated in duplicate into a 96-
well culture plate.  100 µl of either sodium deoxycholate at concentrations ranging from 
0.005% to 5% or preimmune sera at concentrations from 1% to 30% were incubated with 
the aliquoted bacteria for 45 min and 3 hours, respectively.  These bacteria were then 
serially diluted and plated to TSB-C plates for incubation at 37°C.  CFUs were counted 
and compared to controls. 
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In vitro murine macrophage infection model 
 Our in vitro infection model using RAW 264.7 murine macrophages was similar 
to the invasion protocol used by Tempel (170).  4 x 105 RAW 264.7 macrophages were 
plated to a 24 well plate format and incubated overnight at 37°C in 5% CO2.  The next 
day, enough bacteria (determined by OD600) were grown, washed several times and 
resuspended in PBS, so that infections of multiplicity of infections of 10 and 100 bacteria 
per cell were added to respective tissue culture wells for infection for 1 hour.  DMEM 
culture media was then removed from each well and the macrophages were treated with 
DMEM plus 25 µg/ml of gentamicin.  In the two hour experiment, wells were rinsed with 
PBS three times and then given DMEM plus 10 µg/ml of gentamicin for one hour.  The 
wells were then washed three times in PBS before lysis with 1 ml of milliQ water and 
plating to TSB-C plates.  In the 24-hour experiment, the 10 µg/ml gentamicin treatment 
was maintained overnight and lysis by water treatment occurs the next day. 
 
Outer membrane PGA extraction protocol 
 A sodium acetate / glacial acetic acid extraction procedure was used on Bacillus 
species to isolate PGA (80).  10% sodium acetate and 1% glacial acetic acid was added to 
bacterial culture and shaken for at least two hours.  This bacterial mixture was then 
centrifuged at 14K and passed through a .45 µm filter to separate the bacterial cells.  The 
supernatant was mixed with two volumes of ethanol to precipitate the PGA overnight at 
4°C.  The ethanol mixture was centrifuged at 12K for 30 min at 4°C and the pellet was 
resolubilized in a 10% sodium acetate and 1% glacial acetic acid solution and then 
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reprecipitated in two volumes of ethanol overnight at 4°C.  The resulting pellet was then 
dried for 10-15 min and resuspended in 1ml milliQ water. 
 
Anthrone carbohydrate and BSA protein assays 
 The anthrone assay was a spectrophotometric tool to measure the monosaccharide 
concentration of a solution.  The assay involves the hydrolysis of oligosaccharides and 
subsequent dehydration of monosaccharides (usually 400 µl of an organic solution) by 1 
ml of sulfuric acid.  This was mixed with 100 µl of 2% anthrone in ethyl acetate, which 
reacts to form a furfural compound.  These solutions were then read at A260nm after a 10 
min incubation.  Standards were made of increasing concentrations of glucose (84). 
 The BSA assay was based on the Bradford assay, which was used to measure 
solubilized protein.  200 µl of an acidic solution of Coomassie Brillant Blue G-250 dye 
was mixed with 800 µl of either the protein standard or sample and incubated at room 
temperature for at least 5 min.  Similar spectrophotometric readings were made at 
A595nm.  Both of these assays were performed in duplicate. 
 
Dot blot protocol 
 Three µl of extract were dropped onto strips of nitrocellulose and dried overnight.  
Strips were then blocked for at least two hours in 3% BSA in TEN buffer (25mM Tris-
10mM EDTA-200mM NaHPO4, pH7.6).  Primary antibody was added to a final 
concentration of 50 µg/ml and was slowly shaken for two hours.  The primary solution 
was removed and the strips were washed three times in wash buffer (Tris-buffered saline 
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or TBS) for 10 min each.  Alkaline phosphatase-conjugated secondary antibody at a 
dilution of 1:10,000 was added and shaken for one hour.  The strips were washed again 
three times in wash buffer (TBS) and were then incubated in Pierce 1-StepNBP/BCIT 
solution from Pierce for 30 min.  The strips were dried overnight before interpretation 
and analysis. 
 
Desiccation protection model 
 These experiments were modeled after similar experiments performed on 
Azotobacter vinelandii by Campos (23).  Francisella novicida bacteria was grown 
overnight, washed and resuspended in M9 minimal media plus 1% cysteine without 
carbon sources.  Cell density was then measured by OD600, and normalized amounts were 
then aliquoted to separate microfuge tubes, left open, and stored at 30°C in a dry 
incubator.  These samples were then resuspended each day in the same minimal media, 
diluted, and then plated to TSB-C plates for CFU counts.  Experiments proceeded for 
three to four days of desiccation. 
 
Acid resistance assays 
 These assays were modified from assays performed by Foster (52, 133).  
Overnight cultures were subjected to lower pH during stationary phase by the addition of 
drops of HCl.  The pH of these cultures were measured by using pH strips and then 
incubated for two and four hours, shaking at 37°C.  These bacteria were then diluted at 
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these timepoints and plated to TSB-C plates for CFU counting.  Survival data were 
extrapolated from CFU of the wildtype bacteria compared to the mutant bacteria. 
 
Glutamate decarboxylase assay 
 1.8 ml of overnight cultures were centrifuged at 12K for 3 min and the pellet 
washed and resuspended in 1ml PBS.  The bacteria were pelleted again and vortexed 
vigorously.  500 µl of GAD reagent, defined as 1 g of L-glutamic acid, 0.05 g of 
bromocresol green, 90 g of NaCl, and 3 ml of Triton X-100 per liter, was added and 
vortexed.  The solution was incubated at 37°C for four hours, checking for color change 
every hour.  Assays using GAD reagent with Triton X-100 measures internal glutamate 
decarboxylation, thus the α-decarboxylation of glutamate to γ-aminobutyric acid 
(GABA) and carbon dioxide, a reduction reaction consuming an intercellular proton.  
Assays without Triton X-100 were a measure of the ability of the glutamate-GABA 
antiporter to function, thereby neutralizing the surrounding media (28, 130). 
 
Electrospray ionization mass spectrophotometry 
 Dr. Connell Cunningham from Rohm and Haas, a subsidiary of Dow Chemical, 
performed ESI MS without chromatography on three PGA extraction samples: one PGA 
standard from Dr. Kozel of B. licheniformis, and two PGA extracts from U112 and capB 
mutant, respectively, grown at 1M NaCl in Chamberlain’s defined media.  Data 
forwarded was from mass/charge ratios from 100 to over 1000. 
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Amino acid analysis 
 Amino acid analysis was performed by the Amino Acid Laboratory at the 
University of California at Davis, Davis, CA.  Bacterial extracts or samples were mixed 
1:1 with 6% sulfosalicylic acid, which acts to deproteinize the sample, then centrifuged at 
14K and filtered through a .45µm PTFE filter, adjusted to pH 2.2, and then loaded into a 
Biochrom 30 amino acid analyzer for free amino acid analysis. To examine the total 
amino acid profiles, the pellet and supernatant samples were dried slightly in a SpeedVac, 
then transferred to 10ml ampules for hydrolyzation.  Two mls of 6N HCl (containing 200 
nmol/ml norleucine as an internal standard) was added, then purged with nitrogen gas for 
5 min, and sealed using an open flame.  The ampules were then heated at 110°C for 24 
hours, cooled, and then purged again with nitrogen gas to dry.  10 ml of 0.2M lithium 
citrate loading buffer was used to dissolve the samples, filtered through a 0.2 µm filter, 
and loaded into the Biochrom 30 Amino acid analyzer. 
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CHAPTER THREE:  RESULTS OF EXPERIMENTS 
 
Creation of the capB mutant in F. novicida U112 
 The flanking DNA sequences of capB used as the U112 homologous DNA 
sequences for the suicide vector were approximately 980bp and 1050bp, respectively and 
were PCR amplified from U112 genomic DNA using the primers CapCF1, U112 cap R1 
and U112 cap F2, U112 cap R2, respectively.  The erythromycin cassette from pKEK898 
(approximately 1550bp) was amplified from a dilution of this plasmid using the universal 
primers UniUP and UniDN as described by Liu et al (94).  All three PCR fragments were 
amplified using the following Pfu PCR conditions: 1 cycle at 95°C for 10 min, followed 
by 30 cycles of 95°C for 60 seconds; 55°C for 80 seconds; 72°C for 3 min; and an 
extension period at 72°C for 10 min.  These fragments were then electrophoresed using 
1% agarose at 95V and gel purified using the QIAGEN gel extraction kit, resuspending in 
20 ul TE.  All three fragments were placed together as template in a single Pfu PCR 
SOEing reaction using the outside primers CapCF1 and U112 cap R2.  The universal 
sequences from the erythromycin cassette were embedded into the primers U112 cap R1 
and U112 cap F2, which acted as complimentary sequences for the PCR SOEing.  At 
least 25ng of each PCR fragment was needed for the PCR SOEing reaction, using the 
following parameters: 1 cycle at 95°C for 5 min, followed by 30 cycles of 95°C for 60 
seconds; 55°C for 40 seconds; 72°C for 6 min, 30 seconds; and an extension period at 
72°C for 10 min.  The resulting fragment was approximately 3.2kb and once gel purified 
as stated before, it was used as template in a subsequent PCR reaction with the same 
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parameters as the PCR SOEing reaction.  This amplified product was then gel purified 
and 500 ng of this product was used in a 25 µl Sal I restriction digest to cleave off the 
ends of the primer sequences.  At the same time, pBluescript SK+ was propagated in a 
DH5α overnight culture and plasmid DNA was acquired using the QIAGEN miniprep 
kit.  This plasmid was capable of blue / white selection of recombinant DNA colonies due 
its genotype.  Approximately 5 µg of plasmid DNA was used in a 50 µl Sal I restriction 
digest and after 1% agarose electrophoresis, was gel purified and resuspended in 50 µl 
TE.  These two Sal I digested DNAs were mixed together in a 20 µl NEB T4 ligation 
reaction using appropriate controls to determine plasmid religation efficiency and amount 
of uncut plasmid in our plasmid restriction digest.  Approximately 8 µl of these ligation 
reactions were used in 100 µl E. coli transformation reactions, using DH5α made 
competent after CaCl2 washes.  The bacteria-DNA mixtures were heat shocked for 40 
seconds at 42°C and then incubated at 37°C in rich SOC media for 40 minutes before 
plating aliquots to LB agar Ampicillin plates at 100 µg/ml and with both X-gal (80 
µg/ml) and IPTG (20mM).  After several attempts using increased amounts of insert 
DNA, two to three white colonies were inoculated in 2ml of LB Amp100 broth and 
checked the next day via QIAGEN miniprep and 1% agarose electrophoresis.  Two 
clones had MW of approximately 6.2 kb.  These clones were confirmed as correct 
recombinants by Sal I restriction of plasmid DNA and 1% AGE, resulting in excision of 
the DNA insert from the plasmid DNA.  They were also confirmed by PCR of the diluted 
plasmid DNA using the Liu et al. (94). universal primers to amplify the erthyromycin  
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Figure 2.  Method for targeted mutagenesis of the Fn capB gene, which was 
predicted to encode an amide ligase.  PCR SOEing was used to construct a nonpolar 
ΔcapB::Erm allele, which was cloned into pBS SK+ and transformed into F. novicida 
U112 with selection for erythromycin-resistant (100 mg/ml) recombinants according to 
Liu et al. (94).  A double recombination event was necessary for the creation of the capB 
mutant, which was introduced into F. novicida U112 by electroporation. 
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cassette.  The bacteria were inoculated in 4 ml of LB Amp100 broth for plasmid DNA 
from a miniprep, resuspending in 50 µl of milliQ water instead of TE.  1 µg of pEF25 
was electroporated in F. novicida U112 made competent by washes in 0.5M sucrose.  As 
a positive control for electroporation, pFT7T, a derivative of the Maier shuttle plasmid 
pFLNTP7 (105), was used.  This plasmid has a kanamycin resistance cassette and was 
known to create kanamycin resistant Francisella at 15 µg/ml.  TSB-C plates with 100 
µg/ml of erthyromycin were used to isolate recombinant Francisella having a double 
recombination event with pEF25 (Fig. 2).  Several methods were used to ensure that the 
picked, erthyromycin resistant Francisella colonies were targeted insertions into our gene 
of interest. 
 First, approximately 23 Francisella colonies grew on the experimental 
electroporation plates.  These colonies were patched to another TSB-C plus Erm 100 
µg/ml plate as well as used to inoculate 2 ml of fresh TSB-C media at 37°C overnight.  
These cultures were then centrifuged, washed with PBS twice, and resuspended in 200 µl 
of PBS.  2 µl of these cultures were used as template in a Taq PCR reaction using the Liu 
et al. (94) universal primers (most culture media contains ingredients which may inhibit 
PCR reactions) to amplify the embedded erthyromycin cassette.  Genomic U112 DNA 
was used as a negative control and a dilution of pKEK887 was used as a positive PCR 
control.  The parameters of the PCR reaction were as follows: 1 cycle at 95°C for 7 min, 
followed by 30 cycles of 95°C for 30 seconds; 55°C for 30 seconds; 72°C for 1 min, 30 
seconds; and an extension period at 72°C for 7 min.  Upon 1% AGE (Fig. 3), two of the  
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Figure 3.  Screening of the potential recombinant clones via PCR of the 
erythromycin cassette.  I initially screened our Erm resistant Francisella colonies by 
performing PCR of the erythromycin cassette on bacterial inocula using the Uni primers 
shown in table 1.  This PCR product was about 1.1 kb in length.  This product 
demonstrated the existence of the Erm cassette in the genome of our potential mutant.  
Our transformation efficiency was approximately 10%. 
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23 colonies presented a ~1.5kb band which ran at the same MW as the positive control.  
These colonies were termed EF98 and one was selected for the remaining experiments. 
Second, genomic DNA was isolated from capB mutant EF98 using the Epicentre 
DNA purification kit and this DNA was used, along with genomic DNA from U112, as 
template in another Taq PCR reaction using primers CapCF1 and U112 Cap R2, with the 
following parameters: 1 cycle at 95°C for 7 min, followed by 30 cycles of 95°C for 30 
seconds; 60°C for 30 seconds; 72°C for 3 min, 15 seconds; and an extension period at 
72°C for 7 min.  When compared by 1% AGE, the PCR product for EF98 had a slightly 
higher MW than the PCR product from U112 (data not shown).  The difference in MW 
was due to the incorporation of the larger erthyromycin cassette into the genome of our 
recombinant.  Additionally, these PCR products were subjected to Bgl II restriction 
digests and were run on 1% AGE (Fig. 4).  The FTN1451 promoter of the erthyromycin 
cassette has a Bgl II site, which was lacking in the U112 sequence (94).  Two bands at 
1.1 and 1.8 kb were seen for capB mutant EF98, while the wildtype U112 PCR product 
was uncut.  This demonstrates the incorporation of this antibiotic cassette into our gene of 
interest. 
Third, I wanted to determine whether the transcript for capB was lost in our 
recombinant clone.  After overnight cultures were made, RNA was procured from capB 
mutant EF98 and U112 using the QIAGEN RNAEasy kit.  The 260 / 280 ratio for EF98 
and U112 was 1.825 and 1.7713, respectively.  Both RNAs were measured to be 
approximately 2 µg/µl and 1 µl of each was used to create cDNA utilizing the Invitrogen 
RT-PCR System with the random hexamer primer protocol.  A reaction for each was run  
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Figure 4.  Bgl II restriction of capB PCR product.  Our capB mutant EF98 was 
confirmed via PCR using our outermost primer set and restricting with Bgl II.  The only 
Bgl II site present should be the site located inside the promoter sequence of the 
erythromycin cassette (94).  This restriction provides evidence that our antibiotic cassette 
incorporated itself at the capB locus.  The product from wildtype bacteria remains uncut 
at ~3kb. 
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Figure 5 A and B.  RT-PCR for transcriptional analyses.  A) Loss of expression of the 
capB transcript was shown by electrophoresis after RT-PCR using random hexamer 
primers and subsequent PCR with gene specific primers (table 1).  The two clones of 
EF98 do not amplify the 377bp PCR fragment for capB, but do amplify transcripts for the 
genes polA and spoT.  A genomic DNA amplification was also shown as a positive 
control.  B) RT-PCR and subsequent PCR was also performed on the immediately 
downstream transcript of capC, presenting our site-directed mutagenesis of capB as 
nonpolar, thus attributing any changes in phenotype to the loss of capB gene function.  
Negative RT controls demonstrated no DNA contamination of our RNA preparations. 
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without RT as negative control for cDNA (data not shown).  Specific primers for various 
transcripts were used in the subsequent Taq PCR reaction, including capB, polA, spoT, 
and capC (see table 1).  The reaction parameters were as follows: 1 cycle at 94°C for 2 
min, followed by 29 cycles of 94°C for 30 seconds; 56°C for 30 seconds; 72°C for 1 min, 
30 seconds; and an extension period at 72C for 7 min.  The original RNAs were run as 
template as controls for potential DNA contamination.  These samples were analyzed by 
1.5% AGE at 95V (Fig. 5).  The 822bp and 780bp PCR products for spoT and polA were 
seen for both cDNAs of EF98 and U112.  However, the 377bp PCR product for capB was 
not seen for EF98 cDNA, but was present for U112 cDNA.  Just as important, both 
cDNAs amplified the downstream 99bp capC PCR product, demonstrating that the 
targeted disruption of capB was nonpolar and did not affect the transcripts downstream.  
No amplification was seen with the RNA samples (data not shown). 
 
Initial phenotypic characterization of capB mutant 
 Initial investigation into differences between capB mutant and U112 
demonstrated no differences.  Both bacteria grew similarly in two hour timepoints growth 
experiments to stationary phase in both TSB-C (Fig. 6) and CDM.  Final overnight OD600 
for TSB-C and CDM averaged 2.1 and 1.8 for both bacteria, respectively.  Colony 
morphology on Cysteine Heart Agar plus defibrinated blood and 1% IsoVitalex, TSB-C, 
and CDM plates was the same as well, presenting as a smooth, small, opaque colony with 
no change to its edges.  Several experiments were performed to determine if changes to 
the outer membrane by our mutant could be ascertained.  Congo Red was added to 100  
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Figure 6.  Time course experiment of U112 vs. capB mutant EF98 in TSB-C.  There 
was no growth disadvantage for the capB mutant when compared to the wildtype in TSB-
C.  Similar data were obtained for growth in CDM (data not shown).  Overnight cultures 
were also similar in final OD600. 
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µg/ml to TSB-C plates and both bacteria were plated this agar.  This dye binds to 
lipoproteins on the surface of bacteria and turns bacteria various shades of red depending 
on the amount of dye incorporated.  This dye has been used to characterize many O-
antigen mutants in gram-negative bacteria, including Francisella holarctica LVS, in 
which dye was able to bind to lipoproteins normally protected by the polysaccharides of 
the O-antigen.  LVS colonies that normally appear pink in color contrasted with the dark 
red color seen in galactosyl transferase mutants or wbtA mutants.  If a PGA capsule were 
providing any protection to lipoproteins on the surface, there may be a color differential 
seen on these plates (91, 128).  However, no change in color was seen between the 
mutant and wildtype U112 (data not shown). 
 Variable results have been seen in experiments on F. novicida O-antigen mutants 
and their sensitivity to sodium deoxycholate, a water-soluble ionic detergent commonly 
used in cell lysis, liposome preparation, and isolation of membrane proteins and lipids.  
Cowley et al. (39) has stated that the activity of hydrophobic antibiotics and certain 
detergents against the cell membrane of gram-negative bacteria was largely influenced by 
the association between LPS and other molecules of the outer membrane.  If the 
equilibrium of divalent cations was upset by the loss of largely negative components of 
the outer membrane, increased susceptibility to these type of detergents may result.  
Cowley et al. (39) has shown that an wbtA mutant has a increased sensitivity to increasing 
concentrations of sodium deoxycholate.  However, Li et al. (94) has reported an increase 
in resistance of an LVS galactosyl transferase mutant to sodium deoxycholate.  Raynaud  
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Figure 7.  Treatment of bacteria with variable concentrations of sodium 
deoxycholate.  Equal numbers of bacteria were subjected to treatment with 0 to 5% 
sodium deoxycholate (an ionic detergent) for 45 min to disrupt the cell envelope. At 
0.5%, the capB mutant was highly sensitive compared to wild-type.  Sodium 
deoxycholate was a water soluble ionic detergent/bile salt commonly used in applications 
ranging from cell lysis (RIPA Buffer), liposome preparation, and isolation of membrane 
proteins and lipids.  Changes to outer membrane architecture could cause increased 
sensitivity to sodium deoxycholate. 
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et al. (128) has reported no difference in sodium deoxycholate sensitivity between a wbtA 
mutant and wildtype LVS (39, 91, 128). 
I performed similar experiments with our capB mutant to determine whether a 
difference in sodium deoxycholate sensitivity could be seen.  At concentrations less than 
0.05%, no statistical difference could be seen between the capB mutant and wildtype 
U112 (Fig. 7).  However, at 0.5% and 5%, a statisticaldifference was seen in viability 
between these two bacteria.  At 0.5% sodium deoxycholate, up to 44% of the wildtype 
U112 bacteria survived treatment while only 1% of the capB mutant bacteria survived 
(p=.0002).  At 5% sodium deoxycholate, 18% of wildtype survived compared to 1% of 
the capB mutant (p<.0001).  These results suggest an ionic difference at the outer 
membrane of the capB mutant, which may be the loss of a polyanionic barrier helping to 
stabilize the integrity of the outer membrane. 
 
Serum sensitivity assays and in vitro macrophage infection studies 
 Another set of experiments performed to determine changes made to the outer 
membrane include preimmune serum sensitivity experiments.  Preimmune serum has 
bactericidal properties due to the complement proteins it contains, which ultimately leads 
to formation of the MAC complex and cell lysis.  The formation and deposition of 
complement proteins has been shown to occur more readily in the absence of O-antigen 
chains, which cover the lipid A determinants recognized by complement.  This 
phenomenon involves both the classic and alternative complement pathways (158).  
Sandstrom et al. (140) described a capsule-deficient Francisella LVS and its 
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susceptibility to serum treatment.  This killing by serum was ablated by heat-inactivation 
of the serum, demonstrating that complement was directly involved.  These mutants, 
however, were created via chemical mutagenesis (acridine orange), were not genetically 
verified, and were termed capsule mutants due to their rough morphology (140).  It is 
likely that these capsule mutants were actually LPS mutants, due to the familiar 
phenotype seen in LPS mutant serum experiments.  It was believed that in the case of 
several PGA producing bacteria that loss of encapsulation may allow increased 
deposition of complement proteins as well.  To test whether our mutant would have 
limited viability in preimmune serum, I incubated normalized amounts of bacteria, after 
being washed in PBS, with increasing amounts of preimmune rabbit serum, to final 
concentrations of 1, 2.5, 5, 10, 20, and 30%.  After treating cells for three hours in a 96-
well format in duplicate, 100 µl aliquots were diluted in PBS and plated to TSB-C plates 
for measurement of CFUs.  Mean counts for CFUs for these experiments ranged from 
16.5 to 63, and although there were experiments at median serum concentrations which 
demonstrated a statistical difference between U112 and capB, our counts for capB were 
lower than wildtype and there was no significant decrease in CFU as serum 
concentrations increased (Fig. 8).  One would expect reduced viability of both bacteria 
with increased serum, yet this was not seen. 
 Several characterizations of capB mutants in Francisella have shown a decrease 
in virulence in animal infection models, which has been attributed to attenuated 
pathogenesis due to reduced bacterial burden in macrophages and other target cells and 
reduced dissemination.  Su et al. (161) presented a substantial reduction in virulence of  
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Figure 8.  No statistical significant difference between bacteria treated with 
preimmune serum.  Our studies seem to indicate that our capB do not fare as well as 
their wildtype counterpart against blocking the effects of complement.  However, no 
statistical significant difference was seen at any concentration of serum, as increases in 
serum treatment did not demonstrate reduction in number of CFUs. 
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both transposon and direct mutagenesis of capB compared to wildtype in intranasal LVS-
infected BALB/c mice.  In these co-infection experiments, only the wildtype bacteria 
were isolated from the organs of infected mice in these 1:1 ratio infections.  The 
attenuation was corrected via complementation with the capB gene.  Singular murine 
infection experiments with the mutant only were performed as well, compared to mice 
infected only with LVS.  These mutant infections presented a 1,000 fold reduction in 
bacterial burden of the lungs (161).  A negative selection screen by Weiss et al. (186) of 
F. novicida transposon mutants also elucidated capB as encoding a potential virulence 
factor for Francisella.  Genomic DNA from the transposon input bacteria was collected 
as well as DNA collected from the bacteria in the spleens after 48 hours of intraperitoneal 
infection.  These DNAs were used to probe a Francisella microarray, which 
demonstrated an absence of the capB mutant bacteria DNA in the infected spleens (186).  
Several other discovered infection-attenuated mutants were subjected to in vitro 
macrophage infection models, in which bone-marrow derived macrophages were used.  
Two groups of mutants were determined, one having reduced intracellular growth 
capability and the other which replicated just as the wildtype.  The capB mutant was not 
one of the bacteria selected for these experiments. 
 I infected RAW 264.7 murine macrophages in a 24-well format with both our 
U112 wildtype bacteria and the capB mutant.  4 x 105 macrophages were plated per well 
and enough bacteria to provide both a multiplicity of infection (MOI) of 10 and 100 were 
used.  The bacteria were added for an infection period of one hour, then were either 
incubated for an additional hour or 24 hours.  Extracellular bacteria were then eliminated  
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Figure 9.  Macrophage infection model (2hr) demonstrates no potential entry 
differences between U112 and capB.  Murine macrophage cell line RAW 264.7 were 
plated and infected with F. novicida for 1 hr, after which the cells were washed in 
gentamicin (25 mg/ml) for an additional hour, washed with PBS, then lysed with milliQ 
water before plating onto TSB-C plates. At both MOIs of infection, there were no 
significant differences in the number of the capB bacteria compared to WT. 
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Figure 10.  Macrophage infection model (24hr) demonstrates replicative potential 
differences between U112 and capB.  As for the replicative capacity data, at both MOIs, 
capB show a decrease in replication inside the RAW 264.7 macrophages when compared 
to the wildtype U112. 
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with gentamicin washes.  Infected cells were lysed with water and plated to TSB-C plates 
for CFU counts.  No difference was seen at the lower MOI at two hours nor at the higher 
MOI at two hours, indicating no statistical difference in entry between the two bacteria 
types (Fig. 9, 10).  At 24 hours, both MOIs demonstrated approximately a 1.5 log 
increase in CFUs between the wildtype U112 and capB (p<.01).  This data suggests that 
the capB mutant has a reduced intracellular growth capability in macrophages. 
 
Attempted visualization of the PGA capsule of Francisella 
 There were several methods which can used to visualize the capsule of 
encapsulated bacteria.  In certain bacteria which elicit a relatively large capsule, such as 
Streptococcus pneumoniae or Kiebsiella pneumoniae, the capsule can be visualized using 
a light microscope and particular stains.  The PGA capsule of Bacillus, for instance, can 
be visualized using nigrosin in wet or dry mount preparations.  This was due to two 
important factors: the size of the bacterium and the size of its capsule.  Most Bacillus 
species were rather large (1-2 micron), and the capsule appears as a halo around the 
bacteria.  Due to the relatively small size of Francisella (.2 to .4 micron), I had a difficult 
time using these types of techniques to even visualize the polysaccharide capsule.  
Although there appeared to be a halo around our wet and dry preparations of Francisella 
which were grown in repeated passages of CDM, these images were not conclusive of 
encapsulated bacteria (data not shown).  These images also were unable to ascertain the 
difference between a polysaccharide capsule and one made of PGA.  In order to 
specifically visualize a PGA capsule in Francisella, antibodies specific to PGA were 
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needed for use in immunoelectron microscopy studies.  F26G3 was a monoclonal 
antibody against the PGA of B. licheniformis, which has been shown to cross-react with 
PGA from B. anthracis (81).  I also obtained a polyclonal antibody against B. pumilus, 
which reacts with PGA made by Staphylococcus epidermidis (79, 80, 81).  One problem, 
however, was that no experimentation has been performed to determine the limit of 
crossreactivity amongst antibodies to PGA and different polymers of PGA (see Fig. 1). 
 Initially, I used a mounted immunoelectron technique, which has been used to 
visualize Kiebsiella pneumoniae and its capsule.  After both wildtype U112 and capB 
mutant were grown in CDM, these bacteria were washed in PBS and resuspended in 
antisera.  These samples were then fixed in 5% glutaraldehyde-0.1 M sodium cacodylate 
buffer (pH 7.3) with 0.15% ruthenium red.  Following several washes with this same 
buffer but with 0.05% ruthenium red, cells were fixed for one hour in 2% osmium 
tetroxide with 0.05% ruthenium red.  The bacteria were again washed in this buffer with 
0.05% ruthenium red and embedded in 2% agar before dehydration with increasing 
acetone solutions and embedding in Spurr's plastic (116).  Ultrathin sections were cut and 
placed upon Formvar grids for inspection on a JEOL JEM 1230.  Although this process 
was able to provide fair images of the embedded bacteria, the blade of the ultratome 
would push the bacteria in and out of the matrix, not slicing the bacteria as cross sections.  
Although other bacterial capsules have been seen using this technique, it seemed that the 
capsule of Francisella was fairly loosely associated and would not withstand such harsh 
treatment.  It was determined that using a whole mount technique would enhance our 
chances for this visualization. 
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 I then attempted to use a 1% phosphotungstic acid to negatively stain whole 
mounts of bacteria after incubating in CDM.  While this process provided nice images of 
the bacteria capsule, it was not an immunoprocedure in which I could use antibodies to 
differentiate between types of capsule being produced.  Sebastian et al. (150), in his 
immunoelectron micrographs of LVS O-antigen mutants, cited the procedure performed 
by Huebner et al. (70) in their characterization of capsular polysaccharide antigen of 
Enterococcus faecalis and E. faecium.  This procedure did not require any negative 
staining of the whole mounted bacteria, and utilizes antibodies so that specific 
identification of components of the bacterial capsule can be made.  Empiric 
determination of the primary antibody dilution was made and a 1:20 dilution in PBS 
proved effective.  Visualization of reacting antibodies was made with Protein A gold 
colloidal particles at 10nm.  Several milliQ water washes were necessary at the end of the 
procedure to avoid “salting out” on the grids, which occurs when the PBS from the 
antisera was not adequately removed and dries into a salt film with covers the grids, 
making analysis much more difficult (70). 
 Immunoelectron micrographs were obtained of the wildtype U112 and the capB 
mutant when grown in standard media of TBS-C or CDM following treatment with the 
F2G63 monoclonal antibody, and this demonstrated gold particles either at the periphery 
of both bacterial strains or in diffuse material outside attached to the Formvar grids (data 
not shown).  The experiments with the polyclonal antibody also did not seem specific to 
any material on the grids (data not shown).  Capsular material was seen, primarily in the 
CDM preparations, but there was no difference in specificity observed with the 
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antibodies when comparing the U112 and capB samples.  Images of bacteria subjected to 
various environmental conditions will be discussed later. 
 Positive control immunoelectron micrographs were performed on B. licheniformis 
grown in PGA medium at 30°C with shaking at a lower RPM of 200.  These bacteria 
were treated with both the F26G3 monoclonal and the B. pumilus polyclonal.  These 
images revealed diffuse material surrounding most of the gram-positive bacteria seen, 
and the secondary gold particles demonstrated association with this diffuse material in 
equal density as that seen in our experimental grids (Fig. 11).  This association was more 
prominent with the monoclonal than with the polyclonal, as with the experimental grids. 
 
Outer membrane extraction for PGA 
 For more definitive analyses to be performed on the capsule of Francisella, an 
appropriate capsule extraction method was needed in order to perform both biochemical 
and immunological analyses.  In earlier times, capsule extraction for the polysaccharide 
component of Francisella required medium concentration NaCl washes from cultures, as 
was performed by Hood (68).  Detergents, such as dilutions of cetavalon or Zwittergent 
3-14, have been used to strip off the outer layer of bacteria for analysis of the capsule 
(45).  Many other methods have been described as well, ranging from Waring blender use 
to sonication.  To complicate matters, I was looking for a PGA extraction procedure for a 
gram-negative bacteria, as most of the gram-positive bacterial extraction procedures I 
researched included harsher techniques.  Initially, I tried extracting the capsule from 
bacterial cultures using both the agitation of autoclaved glass beads and 10mM EDTA,  
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Figure 11 A and B.  Positive control immunoelectron micrographs of B. 
licheniformis with antibody against PGA.  B. licheniformis was grown with reduced 
agitation at 30°C for several days until turbid cultures were seen.  Cultures were placed 
onto Formvar grids and treated with A) F26G3 monoclonal against B. licheniformis or B) 
polyclonal against B. pumilus from Dr. Rachel Schneerson.  In both cases, the antibodies 
were visualized by secondary gold colloidal particles (10nm) bound to Protein A. 
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respectively.  These procedures were very harsh and resulted in crude extracts which 
required additional enzymatic treatments and had inconsistent initial results with both the 
Bradford assay and the anthrone assay, which measure protein and simple sugar 
concentrations, respectively.  Several protocols were then attempted, including use of 
detergents, such as cetavalon and zwittergent 3-14; and PGA extraction procedures 
against Bacillus anthracis from both Chabot et al. (29) and Kozel et al. (80).  Most of 
these included two to three ethanol precipitations, as both polysaccharide and PGA 
polymers can be precipitated similarly.  The Chabot et al. protocol (29) called for 
treatment of the bacterial supernatant with a nuclease in buffer containing 0.1M Tris, 
10mM MgCl2, 0.1M NaCl, and 0.02% sodium azide.  It also requires a 5% trichloroacetic 
acid precipitation, which can be used in both protein and nucleic acid precipitations, 
depending on the concentration.  I, however, proceeded to use the Kozel et al. (80) 
technique as this procedure incorporates the supernatant of the culture as well as washes 
from the bacteria.  It requires washes with 10% sodium acetate and 1% glacial acetic 
acid, as well as two ethanol precipitations.  These extractions were used in many different 
assays to determine potential PGA levels, but initially, anthrone and BSA assays were 
performed to uncover their biochemical nature.  Extract from U112 grown in CDM 
produces approximately 8 µg/ml and 2.46 µg/ml of glucose equivalent and BSA 
equivalent, respectively.  CDM media itself has at least 3.9 mg/ml of glucose and BSA 
results of fresh media usually were <0.2 µg/ml. 
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Differences in bacterial growth 
 It has been shown that PGA was capable of protecting several bacteria during 
growth in high salt conditions (71).  Most neutralophiles can tolerate salt concentrations 
up to 2M NaCl, whereas at higher concentrations, the loss of intracellular water, thus 
turgor pressure, causes plasmolysis (21).  Staphylococcus epidermidis was one of the best 
known bacteria in which PGA protects this organism due to its high salt environment, the 
human skin.  It has been shown that capB mutants in S. epidermidis not only 
downregulate capB expression in periods of high salt (2M NaCl), but also have a growth 
disadvantage when compared to wildtype (79).  Similar growth experiments were 
performed with our capB mutant in comparison with its wildtype control.  Overnight 
growth in both TSB-C and CDM with incremental increases in NaCl concentration 
(0.1M, 0.5M, 1M, and 2M) were made.  These cultures were started from aliquots of 
overnight cultures in their respective media into test tubes with 3ml of fresh media plus 
the NaCl addition.  There were statistical differences in final OD600 readings in our TSB-
C experiments at 1M and 2M concentrations (p<0.05 and p<0.001, respectively), in 
which the wildtype U112 outgrew the capB mutant (Fig. 12, 13).  Similar data was 
obtained in our CDM experiments, in which the U112 growth advantage was more 
apparent at 1M (p<0.05).  It also seemed that both strains better tolerated with the higher 
salt concentrations in TSB-C than in CDM (at 1M NaCl, OD600 range of 1.4 to 1.7 vs. 0.5 
to 0.7).  This was probably due to the fact that CDM has approximately double the 
amount of NaCl as TSB-C (9.9g per liter in CDM vs. 5g per liter in TSB-C). 
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Figure 12 A and B.  Differences seen in growth cultures in TSB-C when grown at 
NaCl concentrations greater than 1M.  A) When grown in TSB-C, the capB mutant 
showed significant reduction in growth when compared to wildtype U112 at both 1M and 
2M NaCl concentrations for overnight inoculations.  B) The time course experiment 
performed at 1M NaCl in TSB-C demonstrated a significant difference in growth at late 
log phase between the capB mutant and the wildtype U112. 
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Figure 13 A and B.  Differences seen in growth cultures when grown in CDM at 
NaCl concentrations at 1M.  A) In the synthetic media CDM, the capB mutant also 
showed significant reduction in growth when compared to wildtype at both 0.5M and 1M 
NaCl concentrations for overnight inoculations.  B) The time course demonstrates a 
significant difference in OD600 at growth points during log phase when grown in CDM 
plus 1M NaCl. 
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 These growth advantages of U112 over the capB mutant were also demonstrated 
in time course experiments, which demonstrated the growth differential between U112 
and capB.  OD600 readings between the two bacteria, grown in TSB-C plus 1M NaCl, did 
not show a statistical difference in growth until twelve hours after inoculation, whereas 
there was a statistical difference seen at an earlier timepoint (six hours) with growth in 
CDM plus 1M NaCl.  Again, this difference attributed to the higher NaCl concentration 
in CDM.  All of this data suggest that this growth advantage imparted by functional capB 
may aid in Francisella’s persistence in harsh, external environments, such as the skin of 
animals. 
 Another growth condition tested was the absence of ferrous iron in CDM.  There 
have been many experiments performed which show that iron was essential for growth as 
well as intracellular growth and that many bacteria have evolved various tools to confront 
this problem.  Sullivan et al. (162) has described how siderophores are used by 
Francisella in its acquistion of inorganic iron.  These iron-siderophore complexes were 
then bound to receptors at the cell surface, and taken up by the organism.  It has been 
suggested that in other species, PGA, like other anionic polymers, acts to sequester 
cations as a protective mechanism against certain metal toxins (110).  It was also well 
known that under iron-restricted conditions, Francisella tends to upregulate genes needed 
for intracellular survival, such as the genes of the pathogenicity islands as well as 
regulators (86, 115).  As far as the cap operon was concerned, capD, which encodes a γ-
glutamyltranspeptidase, has been shown to have a decreased protein level in a LVS iron-
deficient model (90).  However, Deng et al. (42) have shown via microarray experiments  
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Figure 14 A and B.  Reduction in growth of the capB mutant when grown without 
ferrous iron.  A) Shown was a growth reduction of capB compared to wildtype when 
grown in CDM without iron for overnight culture.  B) A significant difference was seen 
in the mid to late log phase of growth.  Therefore iron restriction has an effect on a capB 
mutant.  It has been suggested that low Fe2+ containing environments may act as a signal 
to increase virulence factors needed for intracellular survival (known increase in 
expression of pathogenicity island genes).  The reverse being that high Fe2+ environments 
may signal adaptation to extracellular environments ie.(potentially encapsulating). 
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of LVS in iron-restricted media, that capD undergoes an increase in expression (1.595 
mean comparative expression level of iron-replete / iron-deplete conditions, n=7).  Their 
data also demonstrates reduced expression of capB in LVS in iron-restricted media (.749 
mean comparative expression level of iron-replete / iron-depleted conditions, n=7).  Deng 
et al. (42) also showed similar expression levels of genes thought to belong to this 
operon, suggesting a common mode of regulation.  Our iron-depleted CDM media 
experiments demonstrated a slight growth advantage by U112 when compared to our 
capB mutant in our overnight growth curve (mean OD600 of 1.260 for U112 vs. 1.156 for 
capB, p<0.05) (Fig. 14).  This statistical difference was seen at hour six during the 
logarithmic phase of growth and throughout until stationary phase was achieved, p<0.05).  
These data suggest that Francisella may, amongst other external stimuli, use free iron 
concentrations as a molecular signal for intracellular vs. environmental growth. 
 Magnesium concentration has been shown to affect PGA production in several of 
the Bacillus species.  It was thought that magnesium was required by the ATPase activity 
in the amide ligase reaction (6, 25).  The usual range of magnesium seen to increase PGA 
production in B. anthracis was 0.05% to 1%.  Overnight cultures from both U112 and the 
capB mutant were used as inocula to initiate new overnight cultures with increasing 
concentrations of MgCl2 as well as MgSO4, respectively.  One µl of culture was used to 
inoculate 2 ml of CDM plus additions of the Mg salt solutions.  The MgCl2 and MgSO4 
concentrations tested were .5, 1, 5, 10, 25, 50, 100, 150, and 200 mM.  There was no 
inhibition of growth seen with either strain at the high concentrations (data not shown).  
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There also was no statistical difference in stationary growth measured by final OD600 
between the wildtype U112 and the capB mutant at any of these concentrations. 
 Another factor that has been demonstrated to influence PGA production in B. 
anthracis was aerobic growth at 37°C with 5% CO2 and 0.8% NaHCO3.  It was believed 
that the CO2 levels indirectly influence the promoter region for transcription of the cap 
operon in B.anthracis (6, 106).  The genetic element recognized as well as the proteomic 
entities involved were not known.  Sodium bicarbonate, however, acts as a buffer to the 
increase in pH due to CO2.  CO2 reacts with water to become bicarbonate and a proton, 
which acts to lower the pH of the media.  However, increasing the bicarbonate 
concentration forces the reaction in the opposite direction, increasing the pH of the media 
until equilibria was reached (106).  Overnight cultures of both U112 and the capB mutant 
in CDM were again used as inocula to prepare cultures grown in 10% CO2 with 0.5 and 
1% additions of sodium bicarbonate for incubation overnight.  There was a decrease in 
overall growth of both bacteria as the concentration of sodium bicarbonate increased 
(1.938, 1.670, and 1.119: mean growth of both bacteria at NaHCO3 of 0%, 0.5%, and 
1%).  However, there was no statistical difference seen in the final OD600 of these two 
strains.  As expected, I observed an increase in pH in both bacterial cultures as level of 
bicarbonate increased, with a slight difference in pH between U112 and the capB mutant.  
The wildtype U112 consistently had a 0.5 pH increase when compared to its capB 
mutant, at all levels of sodium bicarbonate (table 2), using pH strips with a range from 2 
to 9. 
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Figure 15 A and B.  The effects of 10% CO2 and variable concentrations of NaHCO3 
on wildtype U112 and capB mutant.  A) As concentrations of NaHCO3 increased in 
these overnight cultures in CDM at 10% CO2, a reduction in growth of both strains was 
observed.  No significant difference between wildtype U112 and capB mutant was seen 
until 1% NaHCO3.  B) The pH readings in the culture after overnight growth under these 
conditions are shown.  It was consistently observed that the capB mutant had a reduced 
pH when compared to U112.  Both data indicate that optimal growth of these bacteria 
takes place at pH < 7. 
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Immunodot blot analysis for PGA 
 Dot blots were screened using both the monoclonal F26G3 and the polyclonal 
antibody against PGA from B. pumilus, which were obtained as gifts.  Extracts from both 
wildtype U112 and the capB mutant grown in various environmental conditions were 
placed onto nitrocellulose and dried overnight.  These blots were blocked with 3% BSA 
and incubated with each antibody separately in TEN buffer at 50 µg/ml and then 
incubated with secondary alkaline phosphatase-conjugated antibody for visualization via 
NBT/BCIP substrate.  It has been shown that the F26G3 antibody reacts with the PGA 
polymer from B. anthracis, which was in the D-form, as well as the D+L form of B. 
licheniformis.  The polyclonal against B. pumilus has been shown to react with PGA 
made from B. pumilus (D+L) and the PGA made from S. epidermidis (D+L) (79).  
Control blots were performed in which extractions on B. licheniformis and B. subtilis 
cultures grown in PGA expression medium overnight.  PGA provided by Dr. Kozel acted 
as a positive control, as this PGA was extracted using the same procedure.  The F26G3 
antibody reacted with our B. licheniformis extraction and the positive control, but did not 
react with our B. subtilis extraction (Fig. 16).  The polyclonal had strong reactions with 
both the positive control and the B. licheniformis extraction, and had a substantial 
reaction with our B. subtilis extract.  To demonstrate specificity of these antibodies to the 
polymer, an additional control was performed in which aliquots of 25mM and 250mM L-
glutamic acid were blotted and screened.  There was no reaction seen at either 
concentration with the monoclonal. 
U112 and the capB mutant were grown in CDM at 1M NaCl and 50 mM MgCl2, 
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Figure 16 A and B.  Control immunodot blots with PGA extracts from Bacillus 
species and increasing concentrations of L-glutamic acid.  A) To test whether the OM 
extraction procedure was efficient, extractions were performed on several Bacillus 
species (Bl = B. licheniformis, Bs = B. subtilis, Kozel Bl = PGA of B. licheniformis from 
Dr. Kozel).  These extracts were probed with both F26G3 and the Schneerson polyclonal.  
The F26G3 recognized our Bl extract but not our Bs extract.  The polyclonal recognized 
both Bl and Bs extracts.  Both antibodies recognized the positive control from Dr. Kozel.  
B) To further test the specificity of these antibodies for PGA and not singular L-glutamic 
acid, I tested both 25 and 250mM L-glutamic acid solutions against both F26G3 and the 
polyclonal.  No significant signal was seen for these concentrations. 
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Figure 17.  Immunodot blots of PGA extracts of U112 and the capB mutant grown 
in CDM plus 1M NaCl and 50mM MgSO4.  For the F26G3 blots, no significant signal 
was seen for both the capB mutant and the wildtype U112 under both conditions.  Using 
the polyclonal, signals were seen for both capB and U112 at both conditions.  There was 
no differential seen between the mutant and our wildtype extracts. 
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extracted and blotted (Fig. 17).  The monoclonal and the polyclonal reacted well with the 
positive control.  The F26G3 monoclonal only reacted with the Bacillus positive control 
at both conditions.  The polyclonal antibody reacted well with the positive control, but 
only faintly with the wildtype U112 and the capB mutant.  The signals were of equal 
intensity between the wildtype U112 and capB mutant, suggesting just background 
reactivity.  Control immunodot blot experiments were also run using this same antibody 
on S. epidermidis and its capB mutant, which demonstrated no reaction at all with the 
mutant, but positive for the wildtype (data not shown).  The next set of experiments were 
both the extractions and the supernatants collected after growth of both bacteria in CDM 
at 10% CO2 and .5 to 1% of NaHCO3.  Again, no reaction was seen at all with the 
monoclonal except for the positive controls (Fig. 18).  The polyclonal reacted with both 
the U112 and the capB mutant with equal intensity at these conditions as well, presenting 
nonspecificity.  There was an increase in intensity of the signals for the experimental 
extractions in the supernatant blot from 0.5% to 1% NaHCO3.  The next set of 
experiments involved bacteria grown overnight in TSB-C and then subjected to a low pH 
(pH 4) for one hour prior to extraction.  An additional experiment was performed in 
which bacteria, after the pH4 treatment, were centrifuged and lysed in a 2% SDS, 30% 
glycerol, 250mM Tris hydroxyaminomethane buffer and blotted.  This lysis was 
performed to determine whether our gram-positive extraction perhaps was effective in 
processing PGA from our bacteria.  Similarly, these samples did not react with the 
monoclonal, and both U112 and the capB mutant samples reacted weakly and equally 
when screened with the polyclonal antibody (Fig. 19).  Thus our data suggests that none  
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Figure 18 A and B.  Immunodot blots for PGA in extracts and culture supernatants 
of U112 and the capB mutant grown in CDM at 10% CO2 with variable 
concentrations of NaHCO3.  A) Extracts from the strains grown in CDM at 10% CO2 
were probed with both antibodies.  No signal was seen for capB mutant or the wildtype 
U112 at both NaHCO3 concentrations with F26G3.  There was no differential between 
these two bacteria when probed with the polyclonal antibody at both NaHCO3 
concentrations.  B) The supernatants from these same cultures were also probed with 
anti-PGA, yet demonstrated similar results at both NaHCO3 concentrations. 
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Figure 19 A and B.  Immunodot blots for PGA in extracts from U112 and the capB 
mutant grown in TSB-C, then treated for one hour at pH4, and SDS lysates under 
the same conditions.  A) The extracts from both strains did not react with F26G3, and 
there was no differential seen comparing the capB mutant to the wildtype U112 with the 
polyclonal.  B) The SDS lysates were performed in case our extraction procedure was not 
extracting PGA.  Again, no signal was seen from both strains with F26G3 and there was 
no differential seen between the bacteria with the polyclonal. 
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of the above conditions promoted the production of PGA that could be detected 
immunologically. 
 
Immunoelectron micrographs of various environmental conditions 
 Treatment of several PGA-producing bacteria such as S. epidermidis and S. 
haemolyticus with high concentrations of NaCl has induced PGA production (49 ,79).  As 
I have seen growth differences between our bacteria at 1M NaCl, I chose this condition to 
test for production of PGA via immunoelectron microscopy.  Both strains were grown in 
TSB-C supplemented to 1M NaCl for overnight culture.  Using the described procedure 
for creating immunoelectron grids, I observed these bacteria using both F26G3 and the 
Schneerson polyclonal.  Although there appears to be gold particles surrounding bacteria 
of our wildtype U112, similar particles were seen on the mutant grids as well (Fig. 20).  
Images with the Schneerson polyclonal were also not conclusive, with similar numbers of 
immuno-gold particles seen and without specificity to the surfaces of the strains (data not 
shown). 
One of the environmental conditions I analyzed was treatment of overnight 
cultures in TSB-C with HCl.  These cultures were acidified to pH 4 to 4.5 after overnight 
incubation, and shaken for an additional hour prior to addition to the Formvar grids.  
Samples performed at pHs lower than 3 resulted in degradation and lysis of bacteria, 
irrespective of genetic background (17).  One observation at the lower pH was the level 
of aggregation by both bacteria (Fig. 21).  Secondary gold particles were located 
throughout the grid on the polyclonal preparations for both bacteria, with seemingly  
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Figure 20 A and B.  Electron micrographs of U112 and capB grown in CDM at 1M 
NaCl.  Electron micrographs of A) wild-type F. tularensis U112 and B) the capB mutant 
grown at 1M NaCl treated with monoclonal antibody F26G3 followed by gold colloidal 
10 nm particles attached to protein A.  Both images demonstrate no differential of gold 
particles between the two bacteria.  Images were taken at 10,000x on a Jeol JEM-1230 
TEM microscope. 
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Figure 21 A and B.  Immunoelectron micrographs of U112 and the capB mutant at 
pH4 and in M9 minimal media.  Immunoelectron micrographs of wild-type F. 
tularensis U112 and the capB mutant treated with monoclonal antibody F26G3 A) grown 
in TSB-C, then treated at pH4 and B) grown in TSB-C, then resuspended in M9 minimal 
media plus 1% cysteine.  While no differential was apparent in the reduced pH images 
between the bacteria, there may be more gold particles in the M9 media image of U112 
when compared to its mutant.  Images were taken at 10,000x on a Jeol JEM-1230 TEM 
microscope. 
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similar uniformity.  There were beads seen on the bacteria, but just as many beads were 
located on the matrix itself.  It appears that the polyclonal lacked specificity for 
Francisella as there were no concentrated areas seen.  The F26G3 monoclonal was 
localized to diffuse material either on the bacteria or on the matrix, however, the 
secondary beads recognizing this antibody were seen both on the U112 wildtype preps as 
well as on the capB preps, and in equal number. 
Resuspension of our bacteria in M9 minimal media plus 1% cysteine after 
overnight growth in rich TSB-C media was used as a starvation-stress response to see if 
PGA production may be induced under these stringent conditions.  Two ml of overnight 
cultures were centrifuged at 12K, the supernatant decanted, and resuspended in M9 
minimal media with incubation at 37°C for four hours prior to deposition on the Formvar 
grids.  Our analysis of these grids (Fig. 21B) showed less diffuse material on the capB 
mutant grids compared to U112, but the location of secondary gold particles from F26G3 
anti-PGA was not specific for wildtype.  On the capB mutant grids, these gold particles 
were disseminated throughout and did not associate with this material, very similar to the 
pattern seen in past grid analyses with the polyclonal. 
 
Desiccation assays 
 It has been shown that Azotobacter vinelandii creates an alginate encystment 
when placed into a minimal medium with limited carbon sources (23).  This aids in the 
bacteria’s persistence in harsh conditions.  Persistence of Francisella in similar 
environments was known to occur (e.g. due to infections from contact with animal  
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Figure 22 A and B.  Desiccation resistance test.  Overnight cultures of U112 and the 
capB mutant were washed and resuspended in M9 minimal media with 1% cysteine, 
lacking carbon sources.  Bacteria (10 µl) were transferred to tubes and incubated open in 
a dry 30°C incubator.  Each day, tubes were resuspended in minimal M9 media, diluted, 
and plated on to TSB-C plates.  A) There was a significant reduction in CFU formed by 
the capB mutant when compared to wild-type control (Day one shown).  B) These 
numbers were tabulated and it was shown that there was a significant difference between 
these bacteria on day one and two of desiccation, while no colonies were seen with either 
strain after three days. 
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carcasses that have been dormant for some time), although Francisella neither encysts 
nor sporulates (123, 155).  To test the role of capB in desiccation resistance, the U112 
wildtype and the capB mutant were grown overnight in TSB-C media, centrifuged and 
decanted, and resuspended in M9 minimal media plus 1% cysteine without carbon 
sources.  10 µl aliquots were then placed into separate microfuge tubes and incubated in a 
dry 30°C incubator.  At 24-hour intervals, an aliquot would be resuspended in the same 
M9 minimal media, diluted, and plated to TSB-C plates.  These plates were then 
incubated for CFU counts (Fig. 22).  Our results demonstrated that after one day of 
incubation, the U112 wildtype bacteria were very sensitive to desiccation with a drop of 
several logs in CFU.  However, it was substantially more resistant than the capB mutant 
(mean CFUs 1495 for U112 vs. 682.5 for capB, p<0.05).  By the second day, U112 still 
had some viability while the capB mutant showed no CFUs (mean CFUs 72.5 for U112 
vs. 0 for capB, p<0.01).  No colonies were seen on the third day for either bacteria at the 
10-8 dilution.  The data demonstrated that the capB mutant was less resistant to 
desiccation than the wildtype. 
 
Acid resistance assays 
 Due to the environmental advantage seen with the wildtype U112 compared to the 
capB mutant, we next compared their acid tolerance and resistance.  The definition of 
several of these terms regarding acid resistance have been confused, even amongst the 
researchers who have dedicated many years to the study of the mechanisms by which 
bacteria use to manipulate extracellular and intracellular pH.  Acid tolerance was used to 
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describe mechanisms used by bacteria to grow in acidic conditions whereas acid 
resistance refers to mechanisms by which bacteria survive in acidic conditions.  Acid 
resistance and tolerance also applies to exposure to fatty acids as well as fermentative 
acids due to metabolism (17, 28, 38).  There were several systems utilized by bacteria, 
and some of these were dependent on the stage of bacterial growth.  Most neutralophiles 
fare well in a media pH range of 6 to 8.  These acid resistance experiments were modeled 
after similar experiments performed by the Foster lab in which CFUs were counted after 
acid treatment (133). 
Francisella strains were grown overnight in either CDM or TSB-C and then 
normalized aliquots were placed into their respective media that had been acidified to pH 
4 by drops of HCl.  These inocula were then measured by OD600 and placed in the 
incubator at 37°C with shaking.  At timepoints two hours and four hours, aliquots from 
the inocula were removed, measured by OD600 and plated to TSB-C plates for CFU 
counting.  A statistical advantage was seen in the number of CFUs from U112 when 
compared to the capB mutant at both timepoints in the TSB-C experiments (at two hr: 
mean CFUs for U112 was 352.5 vs. 14 for capB, p<0.05; at four hr: mean CFUs for 
U112 was 84.5 vs. 21 for capB, p<0.001).  I also observed a corresponding difference in 
the means of OD600 from the initial inocula reading to the inocula reading at the 
respective timepoint.  The difference in means were as follows: 0.0005 vs. 0.0145 at 2 
hours for U112 and capB, respectively and 0.008 vs. 0.059 at 4 hours for U112 and capB, 
respectively.  The percentage of survival of the capB mutant when compared to the U112 
wildtype control was 4% at 2 hours and 24.9% at 4 hours.  Similar data was collected in  
 93 
 
 
 
 
 
 
 
Figure 23 A and B.  Acid resistance test.  Overnight cultures of U112 and the capB 
mutant were then incubated A) two or four hours (data not shown) in TSB-C medium 
adjusted to pH 4, diluted and plated onto TSB-C plates.  A dramatic reduction in the 
viability of the capB mutant was observed after each period of incubation at low pH.  B) 
Survival plots of these data were charted under the same conditions, using overnight 
cultures of U112 and the capB mutant grown in CDM.  The survival of the capB mutant 
was 44% of control at two hours and 26% of control at four hours. 
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Figure 24 A and B.  Graphical representation of acid resistance data.  Overnight 
cultures of U112 and the capB mutant were incubated two or four hours in A) TSB-C 
medium adjusted to pH 4, or B) CDM medium adjusted to pH 4.  The bacteria were then 
diluted and plated on to TSB-C plates.  Significant reductions in the viability of the capB 
mutant were observed at this low pH in both TSB-C and CDM media. 
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the same experiment except the bacteria were grown in CDM.  The number of CFUs for 
U112 was 675 vs. 300 for capB at the two-hour timepoint (p<0.05) and 913 for U112 vs. 
237 for capB at the four-hour timepoint (p<0.05).  The difference in means were as 
follows: -0.0025 vs. 0.036 at two hours for U112 and capB, respectively and -0.005 vs. 
0.0025 at four hours for U112 and capB, respectively.  The percentage of survival of the 
capB mutant when compared to the U112 wildtype control was 44% at two hours and 
26% at four hours.  For both experiments, there was little evidence of any change in pH 
of the media after both timepoints. 
 A very similar experiment was performed in which overnight culture in TSB-C 
was used to inoculate fresh media for three hours.  These new cultures in log phase were 
then measured by OD600 and then used to inoculate media which was acidified to pH 4.  
These bacteria were then incubated like the past experiment for two and four hour 
timepoints, shaking at 37°C (28).  When plated after the timepoints onto TSB-C plates, 
no CFUs were seen for either strain at the same dilution.  These data suggest that U112 
has an acid resistance mechanism (i.e., survival in acid) which was lacking or inhibited in 
the capB mutant, but this phenomena was only observed after stationary growth by these 
bacteria.  Similar experiments performed with the bacteria in logarithmic growth suggest 
that Francisella novicida U112 may not have an acid tolerance mechanism (i.e., growth 
in acid) (data not shown). 
 
Intracellular and extracellular glutamate decarboxylase analyses 
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 Homeostasis of intracellular pH in bacteria has many facets, and their importance 
in maintaining that balance depends on whether it was gram-negative or gram-positive.  
Most bacteria use membrane ATPases in which protons were removed from the 
cytoplasm to initially lower the intracellular pH.  These mechanisms have a higher 
magnitude of importance in homeostasis of gram-positive bacteria (11, 38).  Another 
mechanism shared by both gram-positive and gram-negative bacteria for pH homeostasis 
was the decarboxylation of certain amino acids.  Extracellular amino acids brought into 
the cell, such as glutamate, lysine, and arginine, can be converted into excreted products 
after decarboxylation.  Intracellularly, this process creates CO2 but more importantly, also 
consumes a proton which leads to the reduction of intracellular pH.  The exchange 
products for glutamate, lysine, and arginine were γ-aminobutyric acid, cadaverine, and 
agmatine, respectively.  These different amino acid decarboxylases in gram-negatives 
have different preferences of induction depending on phase of growth and pH of the 
surrounding media.  In E. coli, the glutamate decarboxylation system was one of two 
amino acid decarboxylation sytems utilized at pH 2.5 (130, 131, 133).  Francisella 
novicida U112 has genes for encoding glutamate and lysine decarboxylases, but not for 
arginine decarboxylation, unlike other species of Francisella (www.biohealthbase.org). 
 In a traditional glutamate decarboxylation system, the two genes gadA and gadB 
encode for isoenzymes responsible for decarboxylation of glutamate.  In. E. coli, these 
isozymes were induced separately depending on pH and growth stage, and in some cases, 
both enzymes were functioning to decarboxylate glutamate.  The gene gadC encodes the 
glutamate / γ-aminobutyric acid antiporter responsible for both the import of glutamate  
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Figure 25 A and B.  The internal and external glutamate decarboxylation assays on 
F. novicida U112 and capB mutant.  Rice et al. (130) has described the measurement of 
glutamate decarboxylation activity using both internal and external GAD assays.  The 
GAD reagent has bromoscerol green which reacts with the level of pH.  A) The internal 
assay (with Triton X-100) was a measure of the activity of glutamate decarboxylases 
present inside the bacterial cell.  Both the capB mutant and the U112 wildtype have 
similar internal glutamate decarboxylase activity, as shown by the light green color.  E. 
coli acts as a positive control for the internal measurement.  B) The external reaction 
(without Triton X-100) was a measure of the exchange of glutamate / GABA at the 
antiporter of the inner membrane.  It was here that a difference was seen between the 
capB mutant and the U112 wildtype, as the wildtype was a slightly deeper shade of blue 
than the capB mutant.  Again, E. coli acts as a positive control and K. pneumoniae acts as 
a negative control. 
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into the cell and the export of γ-aminobutyric acid out of the cell.  Rice’s GAD assays 
(130) for measurement of internal and external glutamate decarboxylation were used to 
determine the relative levels of glutamate decarboxylation in both our wildtype U112 and 
the capB mutant.  Overnight cultures (1.8 ml) of both strains were centrifuged and 
resuspended in 500 µl of GAD reagent and incubated at 37°C for at least four hours.  
GAD reagent with Triton X-100, which permeates the outer membrane, measures internal 
glutamate decarboxylation while GAD reagent without Triton X-100 allows analysis of 
glutamate transport.  These mixtures will turn from yellow to blue for a positive reaction 
and turn clear in a negative reaction.  DH5α E. coli was used as a positive control and 
Kiebsiella pneumoniae was used as a negative control.  Upon mixing and incubation, 
both the U112 wildtype and the capB mutant turned from yellow to green with the GAD 
reagent plus Triton X-100, demonstrating a slightly positive reaction.  With the GAD 
reagent without Triton X-100, however, the U112 wildtype produced a slight shade of 
blue while the capB mutant was close to clear, similar to the negative control.  These data 
show that while both bacteria seem to have functioning and similar internal glutamate 
decarboxylation activity, the U112 wildtype has a greater capability for neutralizing the 
surrounding environment outside the inner membrane than the capB mutant. 
 
Comparison of ESI/MS results from extracts 
 Due to the lack of evidence for the presence of PGA in our Francisella 
preparations, I turned to the sensitive method of liquid chromatography / mass 
spectrophotometry (LC/MS) to detect PGA.  As a positive control, PGA from B. 
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licheniformis was compared to our samples extracted with sodium acetate / glacial acetic 
acid.  Schneerson et al. (148) provided the details of her analysis of PGA-conjugates that 
were used to elicit antibodies to the capsule of B. anthracis.  The analysis of these 
conjugates was by MALDI-TOF LC/MS (148).  Dr. Connell Cunningham, a senior 
scientist from Rohm and Haas, a subsidiary of Dow Chemical, volunteered to perform 
ESI ionization MS on three samples: 1) PGA extraction from B. licheniformis, 2) PGA 
extraction of wildtype U112 grown in 1M NaCl, and 3) PGA extraction of our capB 
mutant grown in 1M NaCl.  The first image was PGA from B. licheniformis, which 
presents m/z (mass/charge ratios) of 187 and 433, thought to be direct evidence for 
glutamic acid and polymer (Fig. 26).  The peaks of 269 and 515 were thought to be these 
same structures but with acetyl groups attached (plus 82 m/z units from the original data).  
This was attributed to the sodium acetate / glacial acetic acid used in the extraction 
procedure.  The second and third images were of wildtype U112 and capB mutant, 
respectively, have many peaks, but none that resemble the actual peaks seen on the PGA 
standard.  There arguably could be small peaks at 187 and at 433 for the wildtype U112, 
but these same peaks were also seen with our capB mutant, and the intensities were very 
low (<100).  Major peaks of the extracts from the wildtype U112 and the capB mutant 
were identical.  Many of the peaks in both U112 and the capB mutant also have acetyl 
groups associated with them, some with multiple groups.  There may be some peaks 
unique to both the capB (peak 437.2) and the wildtype U112 signatures, or that the 
corresponding peaks in the opposite graph were at intensities too low to determine in 
these graphs.  This data demonstrates that the extracts produced at 1M NaCl growth with  
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Figure 26.  ESI mass spectrophotometry on PGA extractions from 1M NaCl.  ESI 
mass spectrophotometry was performed on a PGA standard from B. lichenformis and on 
bacterial-surface extracts (using a sodium acetate and glacial acetic acid procedure) from 
wild-type F. tularensis U112 and its capB mutant grown in CDM at 1M NaCl.  The 
analysis did not show the signature profile of the PGA standard in F. novicida, nor were 
there any obvious differences between U112 and the capB mutant. 
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both the U112 and capB mutants were very similar to each other and do not share 
properties seen in the analysis of the PGA standard from B. licheniformis.  The analysis 
of additional samples by Dr. Cunningham would have been helpful, but as these samples 
were performed free of charge, I was unable to procure his services for additional work.  
Other PGA extracts were submitted to the VCU Mass Spectrophotometry Center, 
however, no intelligible data was obtained. 
 
Amino acid analysis on bacteria samples and extracts 
 To further analyze extracts procured from both the wildtype U112 and the capB 
mutant, samples were sent for analysis to the University of California at Davis Amino 
Acid Laboratory.  Initially, our PGA extracts of both bacteria grown in TSB-C, then 
subjected to pH 4 as well as SDS lysates of both bacteria grown in the same conditions 
were submitted for free amino acid analysis.  These samples were mixed 1:1 with 6% 
sulfosalicylic acid, which acts to deproteinize the sample, then centrifuged at 14K, 
filtered through a .45 µm PTFE filter, adjusted to pH 2.2, and then loaded into a 
Biochrom 30 amino acid analyzer.  The PGA extracts from both bacteria only resulted in 
quantitations for O-phospho L-serine (256 vs. 227 nmol/ml for U112 and capB, 
respectively) (Fig. 27).  O-phospho L-serine, also called L-phosphoserine, was a 
metabotropic glutamate receptor agonist and was structurally very similar to L-glutamate.  
The SDS lysate samples demonstrated some unusual differences, also no difference seen 
in L-glutamic acid (4 vs. 3 nmol/ml for U112 and capB, respectively).  There were, 
however, some large differences in which the U112 values were higher than the capB 
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mutant (L-glutamine, 43 vs. 20 nmol/ml; L-tyrosine, 194 vs. 43 nmol/ml; and β-alanine, 
27 vs. 12 nmol/ml), and others, where the capB values were larger (L-aspartic acid, 6 vs. 
43 nmol/ml; glycine, 86 vs. 123 nmol/ml; L-leucine, 284 vs. 386, and L-phenylalanine, 
117 vs. 170 nmol/ml).  The amino acids potentially involved in pH homeostasis were 
glutamic acid and L-lysine (173 vs. 216 nmol/ml). 
 Additional free amino acid analysis was performed on samples from both strains 
grown in TSB-C, but centrifuged, decanted, and resuspended in M9 minimal medium 
plus 1% cysteine, then incubated for five hours at 37°C with shaking.  This was 
performed due to prior phenotypes seen with this process (e.g. the immunoelectron 
micrographs) and the lack of additional amino acids in this media, which I hoped would 
simplify our results.  I also prepared these samples by simply centrifuging, boiling the 
pellet for five minutes, and recentrifuging to collect both the lysate and the pellet.  This 
was done to avoid any interference due to the SDS.  As recorded, the pellet volume for 
U112 was 473 µl and the pellet volume for capB was 455.8 µl.  As far as L-glutamic acid 
was concerned, there did not seem to be any differences between wildtype and capB in 
the lysate fraction (4.7 vs. 5.3 nmol/ml) (Fig. 28).  There was, however, a difference seen 
in the supernatant fraction (1.2 vs. 2.5 nmol/ml; wildtype > capB) and in the pellet 
fraction (4.6 vs. 3.3 nmol/ml; wildtype < capB).  The amino acid profiles for the lysate 
and the pellet were fairly consistent with each other, except perhaps the L-phosphoserine 
in the pellet fraction (0.9 vs. 0.1 nmol/ml).  Other differences seen in the supernatant 
fraction were as follows: L-asparagine, 1.8 vs. 5.7 nmol/ml: glycine, 16.9 vs. 30.0 
nmol/ml; L-tyrosine, 1.1 vs. 8.9 nmol/ml; and L-lysine, 2.5 vs. 10.4 nmol/ml. 
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 To examine the total amino acid profiles of these M9 treated bacteria, the pellet 
and supernatant samples were dried slightly in a SpeedVac, then transferred to 10ml 
ampules for hydrolyzation.  Two mls of 6N HCl (containing 200 nmol/ml norleucine as 
an internal standard) was added, then purged with nitrogen gas for 5 min, and sealed 
using an open flame.  The ampules were then heated at 110°C for 24 hours, cooled, and 
then purged again with nitrogen gas to dry.  10 ml of 0.2M lithium citrate loading buffer 
was used to dissolve the samples, filtered through a 0.2 µm filter, and loaded into the 
Biochrom 30 Amino acid analyzer.  The glutamic acid data from the total acid analysis 
was as follows: supernatant has 113.1 vs. 135.6 nmol/ml (wildtype < capB) and the pellet 
has 5.95 vs. 4.73 µmol/ml (wildtype > capB).  There were not as many discrepancies in 
the total supernatant data as in the free amino acid data.  However, I did note that L-
aspartic acid was 52.0 vs. 67.6 nmol/ml and L-lysine was 23.1 vs. 32.4 nmol/ml.  Amino 
acid data for the pellet fraction that were divergent: L-aspartic acid was 5.00 vs. 3.92 
µmol/ml, L-alanine was 4.96 vs. 3.64 µmol/ml, and L-lysine was 4.17 vs. 3.31 µmol/ml.  
There was some data pointing to an increase in free glutamic acid in the supernatant of 
the mutant and of total glutamic acid in the pellet of the M9-treated experiment of the 
wildtype U112.  However, there seems to be a decrease in glutamic acid in the total 
amino acid analysis of the supernatant when compared to capB.  The glutamic acid data 
from the SDS-lysate pH 4 subjugation experiment was inconclusive. 
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Figure 27.  The free amino acid analysis profiles for both PGA extracts and SDS 
lysates performed under pH 4 condtions.  PGA extractions from bacteria subjected to 
pH 4 as well as SDS lysates under similar conditions were submitted to the Amino Acid 
Analysis Facility at UCDavis.  There were no significant amino acid profiles seen for the 
PGA extracts, which only resulted in approximately 250 µM of O-phospho-L serine for 
both bacteria.  Several amino acid differences were seen of the SDS lysates, however, 
glutamate concentration comparisons were unremarkable (4 vs. 3 nmol/ml for U112 and 
capB, respectively). 
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Figure 28.  The free and total amino acid analysis profile for bacterial lysates, 
pellets, and supernatants from both bacteria grown in TSB-C, then treated with M9 
minimal media plus 1% cysteine.  Although not enough samples were run to perform 
statistical analysis, the glutamate data for the free amino acid analysis fraction of the 
wildtype U112 supernatant presented double the amount of glutamic acid seen in the 
capB mutant, but these levels were generally low.  Other supernatant differences include 
L-aspargine, glycine, L-tyrosine, and L-lysine.  The only difference seen in the free 
amino acid pellet profile was O-phospho-L-serine.  The total amino acid profiles 
demonstrated a slight difference in glutamic acid in the pellet (5.95 vs. 4.73 µmol/ml, 
wildtype > capB) and a slight difference in the supernatant (113.1 vs. 135.6 nmol/ml, 
wildtype < capB). 
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CHAPTER FOUR:  DISCUSSION 
 
 As stated earlier in this work, the capsule of Francisella has been an enigmatic 
entity for some time, and many researchers have attempted to discern its existence, its 
characteristics, and more importantly, its role in pathogenesis.  Francisella was one of the 
most infectious organisms due to its infectivity and information regarding its unique 
ability to invade and persist in host cells, as well as its ability to evade both the innate and 
the adaptive immune system, would be valuable.  Genetically, information regarding 
virulence genes of the pathogenicity island has vastly improved our knowledge of 
potential regulators as well as genes essential to intracellular survival.  There was, 
however, a paucity of information on effectors and structural components of the outer 
membrane of Francisella (7, 16).  Such information could be used to aid in the design of 
potential vaccine targets as well as potential antimicrobial peptides.  Although the 
weaponization of infectious agents has been prohibited by most governments, the impact 
of such a bioweapon attack on any civilization would be catastrophic, and the 
consequences of being ill-prepared could alter the way we live.  Use of other bioweapons 
in the recent past have been limited in scope, however, as the anthrax attacks in 
Washington D.C. of 2001 demonstrated that although prophylaxis would not be available 
to all, subsequent treatment of those potentially infected proved effective and that 
although the dissemination was not extreme, the radius of exposure was greater than 
initially predicted. 
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 There was limited data on the structure of the outer membrane of Francisella.  
Extractions have been performed on the lipopolysaccharide of Francisella novicida and 
these experiments have uncovered many aspects that vary from the structure of E. coli 
LPS.  It was known that the LPS from Francisella does not elicit the intense cytokine 
response from target cells via interaction with the TLR-4 receptor as other gram-
negatives do, which has been attributed to differences to the absence of a phosphate 
group on the lipid A molecule as well as differences in glycosylation.  It was known that 
this lack of phosporylation at the lipid A molecule gives Francisella resistance to 
polymyxins (62).  It has also been determined that most of the lipid A molecules of the F. 
novicida membrane were without core or O-antigen polysaccharides (180, 184).  These 
free lipid A molecules could be the source of other structural moieties of the outer 
membrane.  Differences have also been noted in the acyl composition of the lipid A 
molecule, with Francisella not only missing an acyl group on the third hydroxyl but also 
having longer fatty acid chain groups (12-14 for E. coli vs. 16-18 for Francisella) (179, 
181).  Another structural component not fully understood was the aspect of phase 
variation of O-antigen polysaccharides.  Blue variants of LVS have been described that 
have demonstrated greater virulence in animal models.  These colonies, under certain 
conditions, such as passage through particular cells or continued culture, can appear to 
change morphology to what was known as the grey variant, with reduced virulence in 
animal models.  It has been determined that this phase variation from blue to grey can be 
a change in the composition of the O-antigen chains of the LPS or modifications to the 
lipid A molecule itself, or potentially both.  It was believed that Francisella novicida was 
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not subject to this phenomenon (40, 65).  Such variations can influence intracellular 
survival and responses to both innate and adaptive immune processes (62).  It has been 
shown that Francisella with certain O-antigen profiles were able to promote greater 
induction of nitric oxide, thus increasing intracellular killing. 
 The other known structural form on the outside of Francisella bacteria was the 
polysaccharide capsule, which has been characterized as possessing mannose, rhamnose, 
galactose, and two forms of fatty acid (68).  These sugars were of a different composition 
than the O-antigen chains, and were sure to alter the outer moieties seen by aspects of the 
immune system (111).  Although this encapsulation can be created in vitro via passage of 
bacteria in Chamberlain’s defined media, neither the ingredients nor the in vivo 
conditions in which encapsulation predominates were known.  It was thought that this 
capsule was an extracellular phenomenon and influences virulence as has been shown by 
both Chamberlain and Golovliov (30, 57).  It has been difficult to attribute the 
characteristics of this structure, as capsule mutants have not been well characterized.  
Sandstrom’s detailed work with Francisella mutagenized via acridine orange treatment as 
capsule mutants were believed to have been O-antigen mutants by several researchers.  It 
was thought that the polysaccharide encapsulation enables these bacteria to be 
phagocytosed easier.  It was believed that the mechanism of action for Francisella 
engulfment into monocytes was the polysaccharide: scavenger or mannose receptor 
interaction (35).  Perhaps the polysaccharide moieties of this capsule enable these 
bacteria to be easily recognized and thus, engulfed by macrophages.  It has been 
suggested that this capsule itself may have a role in the escape of these bacteria from the 
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phagolysosome and may act as a cascade signal to initiate intracellular growth.  Clemens 
et al. (35) demonstrates that Francisella requires both complement and complement 
receptor interaction for the engulfment of bacteria by macrophages.  There may be some 
interaction between complement and the capsule of Francisella which still eludes us. 
 The properties of polyglutamic acid (PGA) would make it a superb virulence 
factor, and as it has been shown in several gram-positive bacteria to aid in minimizing 
immune reactions, avoiding phagocytosis, effectively protect bacteria in stringent 
periods, and perhaps act as a source for trophism.  The fact that the genes responsible for 
PGA synthesis were present and working in Francisella was great evidence for the 
existence of a PGA encapsulation as does many of the phenotypes presented by the 
absence of one or several of these genes.  The generation of minicell E. coli with 
exogenously expressed cap genes was used to determine that the proteins of cap A, B, 
and C were all isolated from membrane fractions after trypsinization (107).  This data, as 
well as the evidence of PGA production from E. coli reengineered with exogenous cap 
genes, demonstrates that PGA can be produced from bacteria other than gram-positives 
(9, 72).  The cap operon itself from the pOX2 plasmid of B. anthracis was flanked by 
IS231 insertion sequences, and theorhetically may be able to move from genome to 
genome.  This initially may be how this sequence has ended up in so many different, 
unrelated bacteria. 
 As stated before, there have been many different transposon systems which have 
been developed for use in Francisella, including those used by the Kawula, Nano, and 
Weiss labs.  Many of these, however, frequently were limited in genomic coverage and 
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have low transformation efficiencies (sometimes 1 mutant per 108 CFU).  There also have 
been problems with the stability of many of the Tn5 based systems (54, 76, 104).  As for 
our purposes, I was not interested in the creation of a mutant library and the genetic 
targets in which I was interested were already known.  Therefore, I decided to investigate 
methods of site-directed mutagenesis to create our mutants in genes thought to be 
responsible for PGA capsule biosynthesis.  Traditionally, many researchers have used the 
Maier series of plasmids (105) as models for suicide vectors for use in mutagenesis of 
Francisella.  These vectors were initially designed as shuttle vectors between Francisella 
and E. coli and were still predominately used in most complementation of allelic 
exchange experiments in Francisella.  These plasmid insertions were thought to be stable 
once in Francisella, but were limited in the methods of transformation.  It was also found 
that working with these plasmids was not as easy as planned, as insertions of Francisella 
genomic DNA could periodically become reorganized upon propagation (105).  Also, in 
order to use these plasmids as a suicide vector, several modifications were necessary such 
as the removal of ORFs responsible for plasmid replication in Francisella.  Dr. Michael 
Harwich was credited with the addition of an oriT sequence in the pFNLTP7 plasmid so 
that it could be used in conjugation experiments for transformation.  Two elements 
missing from these series of plasmids was a Francisella promoter to drive the kanamycin 
resistance cassette in single copy and a levansucrase gene (sacB) used as a 
counterselection marker so that resolution of the integrated plasmid sequence out of the 
Francisella genome would be possible, resulting in our unmarked deletion of our target 
gene (19).  Due to problems attempting to correct for these changes however, I acquired 
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the targeting construct pGIR457 from Dr. Ramakrishnan through a material transfer 
agreement (MTA).  She used the construct to create her mutant of the fslA gene in LVS.  
This construct contained both the Francisella nuo promoter which could be used to drive 
the kanamycin antibiotic cassette as well as the sacB gene as a counterselection agent.  
Growth of the merodiploid colonies on sucrose-containing media will select for excision 
of the plasmid DNA.  Correct recombinants were then screened for loss of the antibiotic 
resistance but loss of the gene of interest.  Simple insertion of our Francisella 
homologous DNA for capB via ligation of our PCR products into pGIR457 minus the 
fslA DNA also was difficult (162). 
 At this time, I acquired both Francisella novicida U112 and plasmids pKEK 887, 
898, 923, and pKEK 1118 from Dr. Karl Klose via an MTA.  The first three plasmids 
were basic target insertion constructs with the antibiotic cassettes erthryomycin, 
kanamycin, and chloramphenicol, respectively.  The plasmid pKEK1118 was the 
construct used to ablate the iglB gene in Francisella novicida.  All of these constructs 
have the FTN_1451 promoter driving their respective antibiotic cassettes as well as the 
universal primer sites, UniUP and UniDN, flanking the antibiotic cassettes.  These 
constructs were capable of nonpolar mutations of any targeted gene, given the correct 
flanking sequences.  As F. novicida is easier to manipulate genetically than its peers, I 
began to customize flanking regions of capB for insertion.  Looking at the plasmid 
sequence of pKEK series, I determined that I could amplify the erythromycin cassette 
from pKEK887 with the universal primers and using PCR SOEing, link the antibiotic 
cassette with the capB flanking regions to create a single sequence.  Once this sequence 
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was created, I used a basic E. coli vector such as pBlueScript SK + as our backbone 
construct to create the suicide vector pEF25.  This also allowed us to utilize blue / white 
screening of recombinants (94). 
 In the past, I had attempted many methods for transformation of our vector DNA 
into Francisella, to include triparental conjugations, cryotransformation, and 
electroporation (54).  The triparental conjugation experiments were time-consuming and 
not very effective, although other site-directed mutants have been created using this 
technique.  It seems, however, that conjugation was a more effective method of 
transformation for species such as F. holarctica and F. tularensis.  Cryotransformation 
was also attempted with limited success using transformation buffers with both 
magnesium sulfate and rubidium chloride to create Francisella competent cells.  Liquid 
nitrogen as well as dry ice in ethanol was used in these processes (14, 120).  Shuttle 
plasmids were transformed, but I had no successful attempts with suicide vectors.  I 
ultimately used the electroporation technique of LoVullo et al. (97) to correctly transform 
F. novicida with pEF25.  Electroporation easily was the more effective method of 
transformation of Francisella, although it does present problems of potential 
aerosolization of bacteria, which may not be an option if using type A organisms.  It 
involves the creation of competent Francisella via washes in 0.5M sucrose, and these 
cells can be stored at –80°C for extended periods of time without losing their competence 
(97).  Our electroporation efficiency for the creation of our capB mutant was 
approximately 10%, which was lower than what was experienced by Klose using 
cryotransformation in his creation of the iglB mutant (94). 
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 The mutant was verified through RT-PCR of isolated RNA for primers specific 
for capB as well as positive controls of other neighboring genes, including the immediate 
downstream transcript of capC.  Its presence in both the wildtype U112 and the capB 
mutant demonstrated that the mutation created was indeed nonpolar, so that ideally, any 
change in phenotype seen could be attributed to the loss of capB.  To also ensure that 
plasmid DNA had not inserted elsewhere in the genome, or that there may be an 
inadvertent insertion of our antibiotic cassette someplace else in the genome, Southern 
blotting of the capB DNA was performed and validated by the singular presence of our 
antibiotic cassette in the capB gene (data not shown). 
 It was seen with the reengineered E. coli that the PGA production was much 
lower than what was seen with other Bacillus species, in the range of 24 mg/L.  These 
genes were under the direction of the pTrc promoter of the expression plasmid (9).  Jiang 
et al. (72) was able to produce greater amounts of PGA (3.7 g/L) with his reengineered E. 
coli expressing the PGA genes of B. subtilis by maximizing culture conditions and using 
the constitutive promoter of the D-amino acid aminotransferase gene of Geobacillus 
toebii.  There has been no detailed characterization of the promoter region of the PGA 
genes in Francisella, and although it has been shown that there was active expression at 
this location via microarray data, there was no knowledge of the type of regulation of 
these genes.  I used many of the culture conditions known to aid in the biosynthesis of 
polysaccharide production as well as traditional conditions known to increase PGA 
production in bacteria such as Bacillus and Staphylococcus epidermidis. 
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 Our initial visual analysis for the production of PGA via classical light 
microscopy with nigrosin was negative as well as attempting to use colony morphology 
growth on Congo Red plates (91, 128).  It was apparent from our nigrosin stains of 
wildtype bacteria that I would not be able to use this technique as a diagnostic for the loss 
of PGA.  This was due to the relative small size of the bacteria, the lack of specificity of 
the technique (PGA vs. polysaccharide), as well as the potential low production of PGA.  
Due to the fact that F. novicida does not appear to form as many O-antigen chains as 
LVS, F. novicida was able to bind greater amounts of the dye than LVS and presents a 
deep red, crimson color vs. the lighter pink of LVS (179).  Variable shades of pink were 
also possible due to changes in O-antigen composition as was seen with phase variation.  
It was thought that if there was extracellular membrane production of PGA that its 
polyanionic nature would prevent the binding of this dye, resulting in lighter color 
colonies of the wildtype U112 in comparison with the capB mutant.  This, however, was 
not seen as both bacteria were similar in both color and colony morphology, even at the 
highest magnification possible.  Even in experiments with both 1M NaCl and 50mM L-
glutamic acid, there still was no apparent morphological difference between these two 
bacteria. 
 Our experiments with sodium deoxycholate, however, pointed to there being an 
ionic exchange difference at the membrane between the wildtype U112 and the capB 
mutant.  As stated before, this detergent has been used to elucidate ionic barrier 
differences in O-antigen mutants of Francisella (39, 91).  With the statistical difference 
seen between these two bacteria at the higher sodium deoxycholate levels, there appeared 
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to be ionic differences.  It was unclear whether this difference was due to lack of polymer 
at the cell surface allowing greater permeability for the detergent or perhaps a subcellular 
difference in charge responsible for this phenomenon.  Measurement of the voltage 
potential between the membranes of these bacteria may uncover whether this occurrence 
was strictly due to charge differences in the bacteria.  Other experiments such as the acid 
resistance assays and the growth advantage seen with culturing in high NaCl media may 
be explained by differential properties of ion exchange between the two bacteria.  There 
could be many possibilities for this potential electrical potential difference (131).  It was 
well established that modifications to the murein lipoproteins, which act as a bridge 
between the peptidoglycan layer and the outer membrane, can cause changes in 
membrane permeability and electrical potential.  Alterations to selective porins could also 
cause such changes.  Perhaps additional membrane permeability experiments could be 
performed to clarify this hypothesis. 
 The results from our serum sensitivity assays suggest that there was no protective 
difference between the wildtype U112 and our capB mutant when treated with 
preimmune serum.  Serum sensitivity was usually a measurement of complement’s ability 
to first bind to the bacterial surface and then become activated to form MAC complexes.  
Complement’s ability to bind to the surface was usually blocked by the O-antigens of the 
LPS, although base components of the LPS were known to help activate complement.  
Neither the interaction nor the effects of the binding of complement and the capsule of 
Francisella were known.  It was known, however, that complement as well as 
complement receptors have an integral role in opsonization and phagocytosis of these 
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bacteria (35).  The capsule mutants of Sandstrom were shown to be serum-sensitive and 
many of these mutants survived by being phagocytosed prior to MAC complex formation 
(140).  As stated above, however, these mutants were now thought to be O-antigen 
mutants.  A recent finding was that Francisella was capable of binding factor H, which 
helps in the inactivation of the alternative pathway.  It was believed that Francisella 
intrinsically has defense mechanisms against both the classical and alternative pathway 
for complement activation (18, 34).  It was not known whether encapsulation of the 
bacteria either by PGA or polysaccharides would influence the level of complement 
killing or the mechanism of action via factor H.  In B. anthracis, PGA capsule mutants 
were shown to be phagocytosed in the absence of complement, suggesting that the 
binding of complement was not essential for phagocytosis (25).  It has been shown, 
however, that PGA does protect against some aspects of the innate immune system such 
as protection of S. epidermidis from defensins and neutrophil granules, which tend to be 
cationic in nature (79). 
 Our data demonstrated a decrease in intracellular replication of our capB mutant 
vs. the wildtype U112 when infecting RAW 264.7 murine macrophages at both two hour 
and 24 hour timepoints.  Although I saw an increase in CFU of our wildtype bacteria at 
MOI 100 after two hours, I believed the overall difference in CFUs was due to properties 
of these bacteria in regards to their intracellular replicative abilities, not a difference in 
binding and engulfment by macrophages.  In theory, the PGA encapsulated wildtype 
bacteria should have reduced numbers of bacteria engulfed by the macrophages (79).  
This was seen with the lower amount of PGA production of S. epidermidis in comparison 
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to that of B. anthracis.  If both bacteria had equal intracellular replicative potential, there 
should be lower numbers of bacteria in our wildtype preparations when compared to the 
capB mutant, due solely to the reduction in engulfment.  CapB mutants of LVS have been 
shown to have lower bacterial burdens in infected animal models, both in co-infections as 
well as direct comparative studies between wildtype and mutant bacteria.  Catheter 
infections of capB mutants in S. epidermidis resulted in reduced bacteria isolated from 
these sites in in vivo murine subcutaneous models when compared to wildtype.  These 
reductions were independent of any biofilm formation.  Similar Francisella mutants of 
intracellular growth have also displayed both reduced bacterial burdens in animal models 
as well as reduced in vitro macrophage infection.  There were, however, some 
Francisella mutants which display in vivo attenuation without differences in intracellular 
replication (186).  Differences in dissemination potential could also cause a difference 
between these two variables.  It should be noted that purified PGA was found to 
disseminate to the liver and spleen, specifically to Kupffer cells, sinusoidal endothelial 
cells, and splenic macrophages, all known targets of Francisella infection (163, 164).  
Therefore the reduced bacterial burden in animal model experiments could be the result 
of both reduced intracellular replication as well as reduced dissemination. 
 The reduced level of PGA production in S. epidermidis may be an excellent start 
to determine whether Francisella was capable of producing a PGA capsule.  This bacteria 
has already shown that it produces PGA at a much lower level than most of the Bacillus 
species (1.2 ug/L vs. 5-10 g/L), and most of our initial work shows that if PGA was being 
made by Francisella, it may be in an amount less than S. epidermidis.  Our initial 
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immunoelectron micrographs with both bacteria grown in either TSB-C or CDM media 
have no specific reactivity when using the antibodies against PGA.  There was diffuse 
material with gold particles localized seen in these immunoelectron micrographs, which I 
believe was capsular material.  However there was no loss of either the gold particles or 
the diffuse material in the mutant preparations.  Gold particle localization to the diffuse 
material seems more specific in the F26G3 antibody preparations than the polyclonal to 
B. pumilus.  There were many different media supplementations as well as culture 
conditions used to try to induce PGA production in Francisella.  Many of these 
conditions presented secondary phenotypes seen which would suggest the production of 
PGA.  These conditions include growth at high NaCl concentrations (1M+), stationary 
growth at low pH (pH 4), and resuspension in minimal media plus 1% cysteine.  
However, for most of these conditions, there was no differential seen in immunoelectron 
micrographs between the wildtype and the capB mutant.  It was unlikely that any 
polysaccharide encapsulation of Francisella would render a PGA capsule undetectable by 
immunological methods as the PGA capsule of S. haemolyticus was still visible with or 
without polysaccharide encapsulation (49).  It also provides support for the biosynthesis 
of two very different polymers for encapsulation in the same bacteria, depending upon 
culture or environment.  It was not known how much PGA was produced from S. 
haemolyticus, but it was stated that it was on the level of its relative S. epidermidis. 
 It was shown that our capB mutant had growth defecits when grown in 1M NaCl 
or higher in both TSB-C and CDM.  This was very similar to the data seen with S. 
epidermidis, in which the PGA capsule was suggested to aid in the binding of water 
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molecules due to its anionic nature.  However, it was also suggested that there may be 
other methods of protection provided by PGA, due to the limited amount made by this 
bacteria.  One simple aspect was that in the gamma linkage reaction by the amide ligase 
between glutamate residues, a water molecule was generated.  This water molecule 
would, in itself, increase the turgor pressure inside the cell (25, 48).  There were instances 
of polyglutamylation of various proteins and other molecules in order to make them more 
hydrophilic.  Certain tRNAs have been shown to undergo such modification as well as 
eukaryotic microtubules.  In the case of microtubules, the addition of several glutamate 
residues to an existing glutamate residue of α- or β-tubulin takes place under certain 
conditions.  Polyglutamylation of tubulin was thought to increase the affinity of tubulin 
for specific MAPS (microtubule-associated proteins) and has been shown to important in 
centriole stability as well as axonemal motility.  This phenomena, however, has not been 
shown in prokaryotic bacteria, only in eukaryotes.  Nor has any clear consensus sequence 
for polyglutamylation been discovered, although sites of polyglutamylation usually occur 
at acidic stretches of amino acid sequence containing glutamate (178).  Another instance 
of polyglutamylation to stabilize molecules was the polyglutamylation of folate 
derivatives by folyl-polyglutamate synthease.  It has been shown that four to seven 
glutamate residues were added to tetrahydrofolate to increase the transport properties of 
this important coenzyme (64).  Such modification of enzymes could be an additional 
component to surviving growth in high salt and other harsh environments and may be 
direct or indirect in which chaperone proteins could be modified to protect against the 
denaturation of other proteins. 
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 There were many facets to osmoprotection which should be discussed.  Most 
enterbacteriaceae, as non-halophilic bacteria, have a salt tolerance up to 1.5 M.  Several 
of the gram-positive bacteria can withstand slightly higher salt concentrations due to 
increased peptidoglycan.  Also bacterial membrane integrity was partially dependent on 
cations interacting with both the negative components of LPS as well as the anionic 
amino acids of the peptidoglycan layer (38).  For most gram-negative bacteria, as the 
environment becomes more hypertonic, the bacteria initially attempts to compensate for 
the solute imbalance by increasing the intracellular potassium ion concentration.  In 
response to this influx of potassium, the cell induces creation of glutamate to mainly act 
as a counterion to the rise in potassium (21).  Potentially, our capB mutant may have 
deficiencies in this arena as well, perhaps unable to import or create this level of 
glutamate internally, or unable to maintain a steady pool of glutamate to counteract the 
potassium.  Deficits in internal glutamate during periods of hyperosmolarity have resulted 
in reduction of growth.  The internal pool of glutamate was maintained by the action of 
three enzymes: glutamate synthetase, glutamine synthetase, and glutamate 
dehydrogenase.  The cycle between glutamine and glutamate has been described as 
glutamine being the internal barometer of nitrogen availability and glutamate being 
responsible for up to 88% of the cell’s nitrogen (189).  In addition, high levels of 
intracellular potassium were not healthy for the cell, and upon long periods of high 
osmolarity, different molecules were used as substitute counterions, for the potassium 
was then effluxed.  Different compatible solutes can be used by the same bacteria and 
some of these include glycine betaine, ectoine, choline, and trehalose (77).  It was 
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believed that the uptake and synthesis of these molecules can be dependent on potassium-
glutamate levels.  It was not known whether polyglutamylation has any effect on this 
form of regulation.  Cyclic ionic amino acids, such as proline, tend to increase in 
concentration during these stressful periods and act as compatible solutes (98).  Could the 
amide ligase be responsible for a cyclic form of glutamate, similar to β-glutamate by 
being metabolically inert, yet functions as a counterion?  In marine methanogens, salt 
tolerance was maintained by using both α- and β- forms of glutamate as counterions to 
potassium.  The β-glutamate was unique in that it was not incorporated into other 
proteins due to its configuration.  It has been described as a compatible solute that was 
metabolically inert (135, 136). 
 Very little information has been obtained regarding iron limitation and its effects 
on Francisella.  The discovery of siderophoric molecules for Francisella was a fairly 
recent find and it was still uncertain how these siderophore-iron complexes were acquired 
by the bacteria, as only one potential iron transporter gene has been discovered upon 
genomic analysis.  It has been shown that iron-starvation of LVS in Muller-Hinton broth 
minus iron requires an overnight incubation prior to analysis for iron-deplete growth, 
whereas F. novicida did not require such prestarvation.  It has been suggested that 
different species of Francisella may have various methods for retaining iron (42, 90, 
162).  The anionic nature of PGA would suggest that perhaps it was used to sequester or 
even attract cationic molecules.  It was known that ferric iron binds to PGA better than 
ferrous, and that this binding was primarily based on the oxidation state of the iron ion, 
although aerobic conditions also favor ferric binding (109).  Studies have demonstrated 
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that, of the various cations usually present in media, the ferric iron has the highest affinity 
for PGA compared to its peers, followed by calcium.  Another phenomenon seen with 
cation-capsule mixtures from B. licheniformis was the reduction in pH without the 
capsule.  The interaction between the anionic amino acid and the metal ion would release 
a proton, lowering the pH of the mixture (110).  Overnight cultures of both our strains 
would usually result in the capB mutant having a slightly lower pH than its wildtype 
counterpart.  Further work was required to determine whether this was due to cation-
capsule interactions.  Additionally, metal-binding to anionic capsule may alter its 
structure and other properties inherent to PGA.  As far as magnesium was concerned, 
there was no difference seen in the growth curves between our wildtype U112 and the 
capB mutant.  It has been shown that increases in MgCl2 have increased PGA production 
in species such as Bacillus.  The magnesium was used by the ATPase in the formation of 
the polymer.  Concentrations as low as 1mM of MgCl2 have been shown to be adequate 
for PGA production in B. anthracis and in the reengineered E. coli.  I tested incremental 
concentrations from 0.5 to 200 mM of both MgCl2 and MgSO4 and no evidence of PGA 
production was evident, nor was there any difference in growth between the two bacteria.  
Although manganese has been shown to be an adequate substitute for magnesium at a 
much lower concentration (µM vs. mM), and, in some cases, produces more PGA than 
MgCl2, similar experiments performed with MnCl2 were as unproductive (6, 9). 
 Our overnight growth curve experiments with various concentrations of sodium 
bicarbonate and 10% carbon dioxide caused increases in the pH of the media as expected, 
which was the probable cause for the differences seen in the amount of growth.  It was 
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reasonable to believe that the increase in bicarbonate made the media too alkaline for 
optimal growth.  Interesting, the pH of the capB mutant was consistently lower than the 
pH of the wildtype U112.  These findings will be addressed in the acid resistance section 
of this document.  The increase in bicarbonate also increased the viscosity of the 
supernatant for both bacteria, which was collected for further study.  The carbon dioxide 
was used in anaplerotic CO2 fixation reactions by Bacillus to maintain the balance of 
many precursors to nucleotides and amino acids, such as oxaloacetate and α-
ketoglutarate.  These were both intermediates in the tricarboxylic acid cycle and α-
ketoglutarate was one of the key components in the synthesis of glutamate.  It was 
believed that Francisella could possibly use similar anabolic pathways for the genesis of 
glutamate for PGA biosynthesis.  It seems, however, that the viscous material isolated 
from the supernatants was mostly sugars from the polysaccharide encapsulation.  Both 
the wildtype U112 and the capB mutant had similar viscosities and anthrone assay 
measurements. 
 As described earlier, many different capsule isolation techniques were attempted 
to procure PGA from our strains under different culture conditions.  The majority, 
however, of these procedures required multiple ethanol precipitation steps, in which most 
ionic polymers would aggregate including polysaccharides and PGA.  It was not known 
whether PGA production in Francisella, if possible, was secreted or attached to the outer 
membrane or peptidoglycan layer (24, 26).  Many of the PGA isolation procedures for 
bacteria such as B. licheniformis were techniques applied solely to the supernatant.  
Conversely, there also were procedures in which the supernatant was removed and PGA 
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isolation was performed as washes to the bacteria itself.  And without an inexpensive and 
accurate measure for PGA, our selection criteria for an extraction were limited.  
However, after narrowing our selection down to the B. anthracis PGA isolation of Dr. 
Chabot and the B. anthracis PGA isolation of Dr. Kozel, I isolated our samples using the 
Kozel technique.  This sodium acetate / glacial acetic acid procedure would allow us to 
collect material from both the supernatant and washes from the bacteria, and as stated 
previously, our limited analyses from these samples were consistent.  These samples were 
stored at –20°C as several papers cited the degradation of PGA polymer without frozen 
storage. 
 As with many of the immunoelectron micrographs performed under various 
conditions, larger scale inoculations of bacteria under similar conditions were used in 
order to isolate PGA from these bacteria.  Immunoblots were performed on bacterial 
extracts at 1M NaCl, 50mM MgCl2, 10% CO2 plus sodium bicarbonate, stationary 
growth at pH4, and controls.  None of the wildtype U112 extracts produced positive 
signals with the monoclonal anti-PGA F26G3, which was shown to have reactivity with 
B. licheniformis, but not B. subtilis.  There were signals seen for the wildtype U112 at 
most of these conditions with the polyclonal, but usually there was no differential 
between the wildtype and the mutant.  This polyclonal was against B. pumilus and was 
used in similar experiments in immunblots with S. epidermidis.  It has been stated that 
this bacteria only produces a fraction of the PGA seen in other Bacillus species, yet the 
polyclonal was able to discern PGA production between a capB mutant and wildtype S. 
epidermidis (79).  The control blot demonstrated reactivity of the polyclonal with PGA 
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from both B. licheniformis and B. subtilis.  With the following data, there may be limited 
specificity with the polyclonal as it seems to bind slightly to all of our extracts (controls, 
wildtype, and deletion mutants).  More information about these antibodies would be 
beneficial to being able to discern the data presented, as no crossreactivity experiments 
with these antibodies has been performed against various forms of PGA.  Another bit of 
information which would be useful was the extent to which these antibodies can bind and 
the specific epitope profile.  The PGA formed from the control bacteria was usually 
composed of polymer of larger MW, such as 100-1000 kDa.  Candela and Fouet (25) 
show antibody-PGA interaction at intervals of 36-38 nm.  It was not known what length 
of polymer was necessary for stable antibody interactions.  Was it possible that 
Francisella was capable of short polymer production, which would provide many of the 
properties discussed so far, yet unable to interact with antibodies designed against larger 
structures?  Antibodies to B. licheniformis, which produces (D+L) PGA filaments, 
recognizes PGA produced from B. anthracis (D), but would it recognize the rarer (L) 
PGA filaments produced by some organisms?  Greater information was needed regarding 
the crossreactivity abilities of these antibodies and the extent of interaction depending on 
polymer length. 
 Most of the protection mechanisms described for protecting bacteria during 
periods of high osmolarity will apply to desiccation as well.  Due to the prolonged nature 
of desiccation, the dynamics of potassium-glutamate should only apply to short-term 
exposure.  Long exposure to slow desiccation under aerobic conditions would involve 
oxidative stresses and protection of necessary proteins.  The accumulation of compatible 
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solutes highly benefits this situation and work by the suggested hypothesis of preferential 
exclusion.  The thought was that the build-up of these preferably metabolically inert 
molecules, which can be at low molar levels of concentration, were not in contact with 
essential proteins and molecules.  This “exclusion” creates a water layer of the remaining 
water molecules around proteins so that it is energetically favorable for the protein to 
maintain its conformation and configuration (123).  Francisella does not possess genes 
for sporulation yet has a substantial desiccation tolerance when compared to other 
persistent bacteria such as Mycobacterium tuberculosis, Yersinia pseudotuberculosis, and 
Moraxella bovis.  Indeed, Francisella has been shown to have comparable desiccation 
tolerance to Streptococcus pyogenes and Corynebacterium diphtheriae (155).  There was 
a lack of dipicolinic acid in Francisella, however it was believed that there were other 
aspects to Francisella which give it unique persistence characteristics.  In our 
experiments, I did not see CFU formation at our standard dilution of 10-8 after three days.  
These results were seen after incubation in minimal media plus 1% cysteine.  
Reproduction of this experiment in a further reduced media may increase our desiccation 
potential, or perhaps a lower dilution.  It has been shown that for Francisella, persistence 
was greater when the level of relative humidity was low.  In fact, these bacteria have been 
shown to have the lowest survival rate at high relative humidity in aerosol experiments 
when compared with several of its peers (155).  Although our experiments were 
performed in a dry incubator at 30°C, perhaps further timepoints could be achieved by 
reducing the ambient humidity.  Another aspect of desiccation was the extent of nutrient 
starvation that can occur.  It is known that glutamate was usually the source of most 
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nitrogen in the bacterial cell.  Could short oligmers of PGA act as a storage stockpile for 
additional nitrogen and carbon in times of nutrient starvation?  Another gene which has 
shown a similar importance as far as virulence in animal studies was cyanophycinase, 
which in cyanobacteria was responsible for the breakdown of cyanophycin in times of 
nutrient starvation as a nitrogen reserve (55).  As can be expected, there was a paucity of 
information on desiccation of any the bacteria on the select agents list.  The resuscitation 
of Francisella after particular stresses was another factor to consider, as passage through 
an animal system has been shown in several types of bacteria to be necessary after 
experiencing stringent conditions for viability.  The plating of the desiccation-stressed 
bacteria onto rich media agar may not provide the appropriate conditions necessary for 
colony growth.  Additional CFUs may have been demonstrated on another agar type, 
such as cysteine heart agar with defibrinated blood. 
 One of the interesting phenotypes I experienced with the capB mutant was the 
acid resistance of the wildtype U112.  Most neutralophiles can tolerate growth in media 
within a range of pH from 5 to 8.  Some of these bacteria have developed systems to exist 
at a slightly greater range, however, the internal pH must remain between 6.5 and 7.5 to 
avoid damage to organelles and macromolecules (11).  Potentially, I learned that several 
of these responses to external stimuli could be related.  There was evidence, in the case of 
E. coli, that changes in external sodium levels may have an effect on pH homeostasis 
(132).  There were many integrated systems involving passive and facilitated ion flux at 
the membrane, external and internal stimulation resulting in induced or repression at the 
transcription level, proton movement at the membrane, and potential post-translational 
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modifications.  The decrease in external pH initially results in influx of potassium, thus 
resulting in the efflux of protons via the potassium / H+ antiport system in an attempt to 
increase the intracellular pH.  It was important to remember that the cell will attempt to 
maintain the proton motive force so that protons will flow down its gradient into the cell 
in order to produce ATP.  Also, the influx of potassium will create a similar scenario to 
high osmolarity, as internal glutamate production will be induced as well as increased 
influx of this amino acid to counteract the positive potassium.  As the media decreases in 
pH, most enteric bacteria use amino acid decarboxylation systems to maintain its 
intracellular pH.  The E. coli model was the standard for these systems as it utilizes three 
different amino acid decarboxylation mechanisms to maintain pH homeostasis.  These 
systems include arginine, lysine, and glutamate decarboxylation.  Each of these amino 
acids was decarboxylated to agmatine, cadaverine, and γ-amino butyric acid (GABA), 
respectively.  Each of these systems has different methods of induction and was 
preferentially used in different stages of growth (17 ,28).  F. novicida has only two of 
these systems, lysine and glutamate decarboxylation.  The glutamate decarboxylation 
system was the most robust of the three and was used in periods of low pH (<3) and in 
stationary phase.  The decarboxylation reaction itself consumes an intracellular proton 
and all of these systems rely on substrate exchange, so that in the case of glutamate 
decarboxylation, glutamate was converted to GABA, which was then exported out of the 
cell in exchange for fresh glutamate. 
 There were also several different regulatory factors which were thought to be 
involved in controlling these reactions.  Regulatory elements such as RpoS, PhoP, and 
 135 
Fur have been shown to modulate and induce acid shock proteins which were used to 
physically deal with damage to macromolecules from exposure to low pH (88).  It was 
interesting to note that the Fur protein appears to have both the ability to repress iron-
related genes as well as activate acid shock genes independent of iron.  The PhoP / Q 
system was a two-component system which has been demonstrated to be important in 
intracellular survival, but that PhoP can also act as an acid shock protein.  It was not 
known whether a Francisella analog has been annotated for this two-component 
regulatory system (139).  RpoS, on the other hand, was responsible for regulating a host 
of genes necessary for stationary phase, low pH, oxidative stress, and heat tolerance.  
RpoS has shown increases in translation but not in transcription in response to changes in 
concentration of inorganic fatty acids, which was directly related to the internal:external 
pH gradient.  It was believed that these inorganic acids as well as anionic molecules such 
as polyamines can be directly responsible for increases in the amino acid decarboxylation 
system (27, 73).  Polyamines were polycationic molecules such as spermine, cadaverine, 
and putrescine, which can be generated de novo or taken in from the environment, and 
can reach millimolar concentrations inside the cell.  Some of these polyamines were 
potential byproducts from the amino acid decarboxylation reaction themselves.  Jung and 
Kim (73) have published research on E. coli which indicates that polyamines have a 
negative effect on cAMP levels, which in turn, has a negative effect on glutamate 
decarboxylation.  Polyamines have also been shown to scavenge oxygen free radicals 
which were created due to the modifications in pH and aeration.  Therefore, they were 
involved in the protection of both nucleic acids and proteins.  It has been demonstrated in 
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Streptococcus pneumoniae that uptake of polyamines increases due to increased 
production of polyamine transporters during periods of oxidative stress.  Polyamines have 
also been implicated in decreasing outer membrane permeability, enhancing 
phagolysosome stability, and promoting apoptosis of polymorphonuclear cells (151). 
 Specifically, the glutamate decarboxylation system was made up of enzymes 
responsible for the decarboxylation event and the antiporter which effluxes the byproduct 
of the reaction as well as influx of fresh glutamate at the inner membrane.  In E. coli, two 
genes encode two versions of glutamate decarboxylase (gadA, gadB) and the antiporter 
(gadC).  In F. novicida, only one gene has been annotated as a glutamate decarboxylase 
(FTN_1701) and the antiporter has been suggested to be encoded by FTN_1529.  
Mutations in these types of genes produce organisms that have limited acid resistance.  
Also in E. coli, it has been shown that the sodium ion concentration has influence on 
gadX and gadW.  These two gene products were known to regulators of gadE, which was 
a direct activator for the glutamate decarboxylation system.  The sodium ion influence on 
these two regulators appears to be posttranscriptional.  Therefore, the same influx of 
sodium experienced during exposure to 1M NaCl or the indirect sodium increase due to 
desiccation could also potentially modify the activity of glutamate decarboxylase or the 
exchange of glutamate for GABA (100, 102, 132).  Dr. Foster’s experiments with the 
GAD assay provides two types of information.  First, by sampling bacteria with the GAD 
reagent with Triton X-100, one was able to determine the relative level of glutamate 
decarboxylation intrinsic to that bacteria via the cytosolic process, ie. gadA, gadB.  The 
decarboxylation of glutamate results in the consumption of a proton, the generation of 
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CO2, and GABA.  Sampling of the bacteria with the GAD reagent without Triton X-100 
measures the ability of the bacteria to exchange the substrates, ie. gadC.  It was thought 
that GABA exchange also will help to neutralize the surrounding media (28, 130).  Our 
data demonstrated that while both the wildtype U112 and capB had the capability to 
decarboxylate glutamate, the capB had a reduced ability to neutralize acidity outside the 
inner membrane.  This reduced ability may explain the mutant’s reduced growth in our 
acid resistance studies as well as the difference in pH of inoculations between the two 
bacteria.  Could the reduced ability for capB to exchange substrates in the glutamate 
decarboxylation process result in reduced intracellular glutamate during these periods of 
acid stress?  Mutants of the reengineered E. coli without the cap operon demonstrated a 
reduced amount of radioactive internal glutamate when compared to E. coli with the cap 
operon (107).  If there was a differential in glutamate / GABA exchange, it may be 
interesting to determine whether the lack of influxing glutamate or lack of effluxing 
GABA or both was the source of acid sensitivity seen.  It has also been shown in the E. 
coli system that synthetic glutamate analogs have acted as inhibitors to this system as 
well (185).  Our data from the acid resistance experiments demonstrated that Francisella 
does not seem to have a functioning log phase acid resistance system.  Although some of 
these systems have been implicated in log phase protection, other mechanisms apparently 
have greater importance (perhaps ATPases or a functioning arginine decarboxylation 
system). 
 Another aspect of pH homeostasis should be considered and discussed as well.  
There have been experiments performed in which the conversion rate of glutamate to  
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Figure 29.  Model of glutamate decarboxylation in E. coli.  This image demonstrates 
the relationship between glutamate decarboxylation activity and the exchange of fresh 
glutamate for GABA at the antiporter of the inner membrane.  Many different control 
mechanisms were thought to be involved in the regulation of glutamate decarboxylation, 
such as polyamines, cAMP, and RpoS involvement. 
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adopted from Jung I. L. and Kim I. G. Journal of Biological Chemistry 278:22846-52 
 140 
GABA was compared to conversion of arginine to agmatine, resulting in a 3:1 ratio.  It 
has been proposed that this greater ratio was necessary due to the chemistry involved in 
the decarboxylation reactions.  The site of decarboxylation for glutamate was the 
carboxyl side chain which has a pKa of 4.25.  Simply stated, this group will remain 
protonated at pH < 4.25.  One of the largest objects of discussion amongst acid resistance 
researchers was that as glutamate enters the cell in a low pH media, this R-group will be 
protonated, only to lose that proton once inside the cell, as the pH will probably be higher 
than 4.25.  It was believed that decarboxylation then occurs, consuming that proton in the 
conversion to GABA.  Many feel that there was some aspect to the system which was 
missing, as there wasn’t a net loss of protons upon GABA exchange.  Proponents of the 
utility of this system believe that the ratio of decarboxylation was the key to this 
conundrum, or perhaps, additional utilization of de novo glutamate which was protected 
from deprotonation prior to decarboxylation.  Still another theory was that glutamine can 
also participate in this exchange and that glutamine dehydrogenase occurs first to create 
intracellular glutamate, which was then decarboxylated.  The pKa of the R group of 
glutamine was 8.18, which means that this group would probably be protonated at most 
physiological conditions. 
 The capability of acid resistance for many pathogenic bacteria provides them with 
the ability to pass through harsh environments such as the host’s stomach in the case of 
Salmonella and hemorrhagic E. coli, to survive in acidic foods such as Listeria 
monocytogenes, or to survive phagolysosomic acidification in macrophages or PMNs (11, 
92).  It has been thought that the passage of Francisella in the pathogenesis of 
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macrophages was that, after looping phagocytosis by the cell, the bacteria escape from 
the early endosome shortly after lysosome fusion.  It has been shown that no acidification 
of these vesicles was necessary for escape and that this acidification was arrested (35, 
144).  These transitions were observable due to specific markers used for identification 
the maturation stages of phagolysosomes and visualization by immunoelectron 
microscopy.  Early endosomal markers such as EEA-1 were seen in infected vacuoles 
very early in infection and subsequent turnover of these markers for LAMP-1 does occur, 
but at a fairly low frequency, with less than 20% of infected bacteria inside vacuoles 
positive for LAMP-1 by one hour of infection.  The majority of bacteria were found in 
the cytoplasm, where for the next four to 24 hours, replicate in the cytoplasm.  It was 
believed that the multiplied bacteria then signal for apoptosis of the host cell and escape 
to infect other cells.  However, a seminal paper by Checroun provided evidence of entry 
of these bacteria into autophagic vacuoles hours after infection and that these vacuoles 
were acidified, staining positive for LAMP-1 and cathepsin D.  Both of these markers 
were indications of lysosome fusion and acidification (31).  These bacteria-filled 
vacuoles were also positive for MDC or monodansylcadaverine, an autophagic probe, 
and LC3, an autophagosomal membrane-associated protein.  Additional proof of 
acidification of these autophagic vacuoles was the accumulation of LysoTracker Red 
DND-99 dye, which permits estimation of the pH of the vacuoles.  It has been suggested 
that this method of intracellular trafficking may be dependent on IFN-γ activation.  In 
addition, autophagic processes have been observed to occur as early as one hour after 
infection. 
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 The knowledge of this transition, however, may provide insight into the virulence 
of the wildtype U112 when compared with the capB mutant.  I have experienced several 
phenotypes which have demonstrated the acid resistance of the wildtype.  This resistance 
has been shown to occur after stationary phase growth as there was no growth seen at low 
pH (pH 4) during log phase growth.  These conditions would be very similar to the 
pathogenesis of Francisella in macrophages.  It was thought that Francisella did not 
require genes necessary for acid resistance due to the fact that the bacteria were found to 
escape the phagolysosome prior to lysosome fusion.  This premise must now be 
reexamined as these genes now may be necessary to allow Francisella to survive 
residence in these autophagosomes.  Francisella does possess lysine decarboxylation 
genes in addition to the glutamate decarboxylation machinery and could potentially use 
both of these mechanisms to protect itself while in the autophagosome.  As Francisella 
does not seem capable of growth at these low pHs, it would make sense to escape such 
exposure early in infection, but once the bacteria have replicated to a suitable number (ie. 
after cytoplasmic replication), survival at low pH would give these bacteria an 
appreciable advantage.  This information would help explain the reduction of bacteria in 
the capB mutant in our macrophage infection model as well.  With the inability to 
withstand the low pH of the autophagosome, replicated bacteria of the capB mutant 
would be subject to hydrolases once entering the autophagic pathway.  It was not known 
how the lack of an amide ligase would result in reduced glutamate exchange, thus 
reduced acid resistance.  It was also not known whether the autophagic process was 
mediated by the bacteria or by the host, as examples of both scenarios do exist (41).  
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Another question that requires investigation was iron acquistion for the replicating 
bacteria.  It has been shown that acidification promotes the release of free iron and was a 
must for many intracellular pathogens in order to acquire iron.  Perhaps the siderophores 
produced by Francisella were transiently required during intracellular replication and 
other, less efficient iron acquistion methods were necessary during autophagosome 
residence (162). 
 Our ESI/MS submissions suggest that the 1M NaCl data for our wildtype U112 
and capB extracts did not resemble the mass/charge profile for PGA from B. 
licheniformis.  Limited identification of the source of the peaks for the wildtype U112 
and capB can be made and comparison to MS data from LPS samples from the literature 
was not informative (181).  Additional separation of our extracts via the use of ionic 
columns does not seem to have been necessary for comparative analysis.  Perhaps 
additional submissions of other environmental conditions may have shed some insight 
into the structures of the components in these extracts as well as additional controls for 
PGA.  In the Schneerson paper, the PGA samples were derivitized with 
heptafluorobutyryl isobutyl esters after hydrolysis with HCl, and were separated by HP-5 
0.32x30 mm glass capillary column (148).  Perhaps separation and derivitization was 
necessary for accurate analysis of PGA polymers.  It seems that the derivitization allowed 
for the determination of the different enantiomers of glutamic acid.  There again, there 
was a lack of information on mass spectrophotometry of PGA for us to draw any 
conclusions from our previous data, other than the extract samples of our two bacteria 
were very similar and that they do not resemble the PGA profile of B. licheniformis. 
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 Our survey of the free amino acid demonstrates no glutamic acid or any typical 
amino acid for that matter in the PGA extract of either bacteria at pH 4.  There were, 
however, substantial amounts of L-phosphoserine found in these extracts, which was 
structurally similar to L-glutamate.  Analogs to glutamate have been shown to inhibit the 
glutamate-dependent acid resistance system.  It has been shown that 1.5mM of L-trans-
pyrrolidine-2, 4-dicarboxylic acid (L-PDC) can significantly inhibit the in vitro glutamate 
decarboxylation of E. coli (185).  This blockage takes place at the glutamate / GABA 
exchange antiporter (gadC) and was found to be strictly competitive.  Perhaps L-
phosphoserine was having a similar effect in our acid resistance studies, acting as a 
competitive inhibitor to glutamate and disrupting the glutamate decarboxylation cycle.  
Additional tests could be performed to determine if this was a likely scenario.  There was 
limited information on the specificity of the gadC antiporter but such information could 
be useful to identify potential glutamate analogs that may obstruct this system.  I 
consistently see a difference in L-phosphoserine in favor of the wildtype U112, at pH 4 
and with the minimal media.  The SDS samples show an increase in glutamine when 
comparing the U112 to the capB mutant, which may be an indication of glutamine 
utilization for decarboxylation.  Again, a greater understanding of Francisella’s 
glutamate / GABA antiporter was necessary.  The minimal media data presented both a 
difference in free glutamic acid when comparing the supernatants and the pellet fractions.  
If PGA were part of the supernatant fraction, one would expect the glutamic acid content 
to favor the wildtype.  The pellet fraction presents a lower glutamic acid amount for the 
mutant when compared to the control, however, this may be due to PGA, another source 
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of polyglutamylation, or just a difference in free glutamic acid.  The other amino acid 
potentially involved in acid resistance was lysine, in which I consistently see higher 
amounts in our mutant supernatant samples than in the wildtype.  This trend may also 
warrant additional attention as this resembles what was seen with glutamate in the 
supernatant.  Analysis of the total amino acid data also demonstrates higher amino acid 
content of glutamate and lysine in the supernatant fraction for the mutant, as the pellet 
information paralleled the free amino acid profile for glutamate.  As with the MS data, 
additional studies were needed to draw more substantive conclusions regarding PGA 
production. 
 Many different experiments have been performed by various researchers, both 
Bacillus and Francisella alike, to determine whether Francisella was capable of 
producing a capsule consisting of polyglutamic acid.  Under the conditions tested, it 
seems that the existence of a PGA capsule for Francisella was still enigmatic, although 
these studies may have clarified some of the idiosyncrasies which make Francisella such 
an efficient pathogen of cells such as monocytes and macrophages.  It was still unclear 
how the loss of a gene such as an amide ligase can result in a reduced potential for 
replication in macrophages as well as reduced potential to survive desiccation.  It may be 
possible that gene has an additional function other than the γ-bridging of glutamic acid.  
Further tests should be able to discern this, as radioactive studies using isotopic glutamate 
or glutamine may not elucidate the existence of a PGA capsule, but may clarify the 
glutamate:glutamine equilibria of these bacteria.  Studies into the glutamate / GABA 
antiporter should also be performed to determine whether there actually was a differential 
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in activity of that inner membrane protein.  As mentioned before, a greater knowledge 
and repetorie of antibodies specific for different forms of PGA would be useful, as 
visualization immunologically may be still be possible.  And it could stand to reason that 
the appropriate conditions for polymerization have not been discovered.  Investigation 
into the expression levels of the genes potentially responsible could also elucidate which 
conditions favor expression as would access to steady mass spectrophotometry.  As 
isolation of these membrane complexes was rather difficult, some proteomics research of 
recombinant proteins may uncover affinities and relationships with other inner membrane 
proteins, which may clarify the poly-γ-glutamate synthetase complex’s potential role, if 
any, in Francisella. 
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